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HAPLOTYPE-BASED ASSOCIATION STUDIES: 
APPROACHES TO CURRENT CHALLENGES 
 
Mark Levenstien, Ph.D. 
The Rockefeller University 2007 
 
 Haplotype-based association studies have greatly aided researchers in their 
attempts to map genes.  However, current designs of haplotype-based association studies 
lead to several challenges from a statistical perspective.  To reduce the number of 
variants, some researchers have employed hierarchical clustering.  This thesis starts by 
addressing the multiple testing problem that results from applying a hierarchical 
clustering procedure to haplotypes and then performing a statistical test for association at 
each of the steps in the resulting hierarchy.  Applying our method to a haplotype case-
control dataset, we find a global p-value.  Relative to the minimum p-value over all steps 
in the hierarchy, the global p-value is markedly inflated.  The second challenge involves 
the inherent errors present when prediction programs are employed to assign haplotype 
pairs for each individual in a haplotype-based association study.  We examined the effect 
of these misclassification errors on the false positive rate and power for two association 
tests—the standard likelihood ratio test (LRTstd) and a likelihood ratio test that allows for 
the misclassification inherent in the haplotype inference procedure (LRTae).  Our 
simulations indicate that 1) for each statistic permutation methods maintain the correct 
type I error; 2) specific multilocus genotypes that are misclassified as the incorrect 
haplotype pair are consistently misclassified throughout each entire dataset; and 3) a 
significant power gain exists for the LRTae over the LRTstd for a subset of the parameter 
settings.  The LRTae showed the greatest benefit over the LRTstd when the cost of 
 
phenotyping was very high relative to the cost of genotyping.  This situation is likely to 
occur in a replication study as opposed to a whole genome association study.  The third 
challenge addressed by this thesis involves the uncertainty regarding the exact 
distribution of the likelihood ratio test (LRT) statistic for haplotype-based association 
tests in which many of the haplotype frequency estimates are zero or very small.  By 
simulating datasets with known haplotype frequencies and comparing the empirical 
distribution with various theoretical distributions, we characterized the distribution of the 
LRT statistic as a χ2 distribution where the degrees of freedom are related to the number 
of the haplotypes with nonzero frequency estimates.  Awareness of the potential pitfalls 
and the strategies to address them will increase the effectiveness of haplotype-based  
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CHAPTER 1:  BACKGROUND 
 
1.1 A historical perspective of genetic mapping 
Over the past the twenty-five years, human gene mapping has developed into a 
highly effective tool for localizing mutations which lead to disease.  The startling rate of 
advancement in molecular biology has provided the field with genetic and physical maps 
of excellent quality while more efficient computational algorithms and more powerful 
computing systems have permitted researchers to analyze larger datasets containing a 
greater number of marker loci.   
A wide variety of statistical approaches and study designs has been employed in 
the effort to map human disease genes.  Although the statistical methodology had been 
developed (Morton 1955) and the algorithm refined (Elston and Stewart 1971) as well as 
incorporated into software (Ott 1974) much earlier, linkage studies experienced new 
levels of popularity and successfully mapped many disease genes starting in the 1980s 
(Gusella et al. 1983; Monaco and Kunkel 1988; Kerem et al. 1989).  Such studies proved 
to be successful for mapping Mendelian disorders—disorders whose genetic basis 
involves a single major gene.  These diseases show high penetrance (individuals 
possessing one or two copies of the mutant allele at the disease locus have a high 
probability of showing the disease phenotype) and tend to follow classical modes of 
inheritance.  Specifically, linkage analysis has been instrumental in localizing genes 
responsible for cystic fibrosis (Eiberg et al. 1985; Knowlton et al. 1985; Wainwright et al. 
1985; Schmiegelow et al. 1986; Kerem et al. 1989; Riordan et al. 1989), Duchenne 
muscular dystrophy (Monaco and Kunkel 1988), Huntington disease (Gusella et al. 
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1983), Charcot-Marie-Tooth disease (Ouvrier 1996), retinitis pigmentosa (Sullivan and 
Daiger 1996), certain forms of early-onset breast cancer (Hall et al. 1990), and certain 
forms of Alzheimer disease (Levy-Lahad and Bird 1996; Rademakers et al. 2005), among 
other Mendelian disorders.  Although linkage analysis has been shown to be an effective 
tool for Mendelian disorders, the linkage results provide wide candidate regions which 
require additional fine-mapping typically performed using linkage analysis (or 
association studies) with a denser marker map in the region where linkage was initially 
detected.  As part of a fine-mapping analysis to narrow a candidate region, researchers 
may reconstruct the haplotypes for the family and identify the largest section of the 
haplotype shared by the affected study individuals (Seri et al. 1999; Bolino et al. 2000; 
Lo Nigro et al. 2000; Paluru et al. 2003).  In this context, haplotype phasing is determined 
using the familial relationships and minimizing the number of recombination events. 
In addition to linkage analysis, other statistical methods have greatly aided in the 
mapping of human traits.  Association studies (case-control studies) aim to find a genetic 
variant that appears with the disease state more often than it should by chance alone.  
When a new mutation arises in a population, the alleles at nearby polymorphic sites on 
the mutated chromosome will be initially coupled with the mutant allele.  As the mutation 
is inherited by new generations, recombination events will eventually cause this coupling 
effect to decay.  However, a state of coupling or linkage disequilibrium (LD) may remain 
detectable if the disease and marker loci are in sufficient proximity to one another so that 
recombination events between the two loci are rare, and, consequently, the decay of the 
coupling effect is very slow (Ott 1999).  That is, a certain genetic variant may be 
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associated with the disease state such that the frequency of the genetic variant is higher in 
cases than in controls. 
Linkage and association differ fundamentally.  For linkage analysis, the specific 
genetic variants (alleles) serve as a means to examine the linkage properties of the region 
or estimate the amount of recombination between the marker and the disease.  In contrast, 
for association studies the genetic variants (alleles, genotypes, or haplotypes) themselves 
are the center of the test and may be directly responsible for the disease phenotype.  That 
is, the reason an association is detected between a genetic variant and a disease is that the 
variant itself causes the disease state (direct association) or is in high LD with a mutation 
that causes the disease state (indirect association) (Ott 1999; Cordell and Clayton 2005).   
The first major finding from genetic association studies occurred in the late 1960s 
and early 1970s when a number of researchers detected an association between a number 
of different diseases and the HLA (human leukocyte antigen) loci.  Perhaps the best 
known of these associations is that between ankylosing spondylitis and HLA-B27 
because of the large number of studies able to replicate the finding (Brewerton et al. 
1973; Schlosstein et al. 1973; Levitin et al. 1976; Brautbar et al. 1977; Contu et al. 1977).  
These discoveries generated increased interest in association studies.  However, because 
the LD required to detect association exists over a short distance from the marker locus, 
such association findings were rare until genetic maps with a higher density of markers 
were developed.  Since the regions over which LD can be detected do not extend as far as 
linkage peaks, association studies traditionally have been utilized in human genetics in 
order to fine map after an initial linkage analysis has implicated candidate genes for 
follow up studies.  A major disadvantage of association studies is that they are 
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susceptible to inflated false positive rates in the presence of population stratification or 
admixture (Simpson 1951; Li 1955; Gorroochurn et al. 2004; Heiman et al. 2004) since 
differences in allele (genetic variant) frequencies between cases and controls may only be 
the result of differences in ethnicity between the case and control populations rather than 
differences related to the disease state itself. 
As a way to protect against this situation, other methods such as the haplotype 
relative risk (HHR) test (Rubinstein et al. 1981; Falk and Rubinstein 1987; Thomson et 
al. 1989), the haplotype-based haplotype relative risk (HHRR) test (Terwilliger and Ott 
1992), and the Transmission Disequilibrium Test (TDT) (Spielman et al. 1993; Spielman 
and Ewens 1996; Ewens and Spielman 2005) applied family-based controls rather than 
population-based controls.  In particular, because of its ability to use the genetic 
information from multiple affected siblings, the TDT and other family-based association 
methods gained popularity and successfully aided in mapping genes for many diseases 
including psoriasis (Helms et al. 2003; Helms et al. 2005) and sitosterolemia (Lee et al. 
2001; Gordon et al. 2004).  Although the TDT solved the problem caused by working 
with admixed populations (excluding the situation involving extreme admixture 
(Lazzeroni and Lange 1998)), the test requires additional sample collection and increased 
costs to maintain the same power as association studies (Morton and Collins 1998).  In 
addition, the TDT has the undesirable property of an increased false positive rate in the 
presence of genotyping error (Mitchell et al. 2003) or absence of parental genotype data 
(Curtis and Sham 1995).  Simulation studies have shown that genotyping errors and 
missing parental genotypes interact to increase the false positive rate of the TDT (Barral 
et al. 2005). 
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Several factors have contributed to a rise in popularity of the case-control 
association studies despite the issues related to population stratification.  New methods 
have been developed which can account for population structure in case-control studies 
and, therefore, avoid the spurious associations between genes and disease that result from 
admixed populations.  These methods utilize additional genetic markers to correct for the 
stratification using one of two approaches—genomic control (GC) (Devlin and Roeder 
1999; Bacanu et al. 2000; Devlin et al. 2000; Devlin et al. 2001) and structured 
association (SA) (Pritchard et al. 2000a; Pritchard et al. 2000b; Pritchard and Donnelly 
2001; Kohler and Bickeboller 2006).  The GC approach assumes that the effects of 
population stratification should be equal across the entire genome.  From the test results 
of many polymorphisms at genomic regions unlikely to harbor a disease gene, the GC 
approach estimates the amount of “overdispersion” or inflatedness present in the statistic 
used to detect association.  This estimate is then used to correct the test statistic in regions 
under consideration for association.  Simulation studies have shown that under some 
circumstances GC methods may not completely eliminate the inflation in false positive 
rate due to population stratification and under other circumstances may significantly 
reduce power (Shmulewitz et al. 2004).  In contrast to GC, the SA approach uses many 
polymorphisms to classify individuals into subpopulations with high degrees of genetic 
similarity.  (The method proposed by Pritchard et al. allows for admixture in the sense 
that individuals may be classified as possessing the genetic ancestry of several different 
subpopulations.)  With subpopulations established, the next second step in the SA 
approach performs a test for association that conditions on the inferred subpopulation 
membership.   
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Besides the development of these defenses against the dangers of population 
stratification and the relative ease and cost-efficiency offered by case-control study 
designs, in the late 1990s new technological resources, including sequence data from the 
Human Genome Project, facilitated single nucleotide polymorphism (SNP) discovery 
efforts and high-throughput SNP genotyping (Collins et al. 1998).  Theoretical studies 
show genome-wide association mapping to be a very powerful strategy for localizing 
genes related to complex traits (Risch and Merikangas 1996; Risch 2000).  This potential 
for genome-wide association using SNP markers has prompted companies, such as 
Affymetrix Inc. and Illumina, Inc., to develop as well as manufacture gene arrays and 
platforms with the ability to provide genotypes for thousands of SNPs.  In addition, the 
work of the International HAPMAP Project, an organization dedicated to describing the 
patterns of human genetic variation by developing a map of the linkage disequilibrium in 
the human genome, provides a valuable resource for efficient SNP selection for custom 
chip studies (International HapMap Consortium 2003; International HapMap Consortium 
2005).  Furthermore, large-scale genome-wide association studies have already proven 
successful for identifying genes related to age-related macular degeneration and obesity 
(Klein et al. 2005; Herbert et al. 2006).  A final reason researchers are attracted to the 
case-control design is the plausibility that in the future large databases containing 
genome-wide information for controls will facilitate highly efficient case-control studies. 
As described briefly above, genetic association tests aim to detect an association 
between a genetic variant and the disease state.  Although traditionally the genetic variant 
under investigation has been an allele (Botstein and Risch 2003), a genotype, a single 
haplotype, or even a diplotype (haplotype pair) can be the focus of a case-control genetic 
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association test.  The alleles present at multiple genetic markers inherited from the same 
parent form a haplotype (Ott 1999).  Often haplotypes are comprised of alleles on the 
same chromosome (Brumfield et al. 2003).  Each of the forms (allelic, genotypic, 
haplotypic, and diplotypic) of association testing may have advantages under specific 
circumstances.  For instance, test statistics that utilize single allele frequencies (or single 
haplotype frequencies) may not be valid when the genotype frequencies (or diplotype 
frequencies) deviate from Hardy Weinberg Equilibrium (HWE) (Sasieni 1997).  
However, allelic (or haplotypic) tests of association generally are more powerful than 
their genotypic (or diplotypic) counterparts because these tests have fewer degrees of 
freedom (Agresti 1996). 
With the advent of the HAPMAP project (International HapMap Consortium 
2003; International HapMap Consortium 2005), the popularity of a relatively recently 
developed form of genetic association analysis, haplotype-based case-control genetic 
association studies, has grown markedly.  It has been suggested that association studies 
utilizing haplotypes formed from SNPs may be more powerful than single locus 
association (Martin et al. 2000; Akey et al. 2001; Fallin et al. 2001; Morris and Kaplan 
2002; Zaykin et al. 2002; Botstein and Risch 2003; Clark 2004; Clayton et al. 2004; De 
La Vega et al. 2005; Ellis et al. 2005) .  One reason haplotypes may provide a power 
advantage over single SNPs in association studies is that the combined effects of multiple 
sequence variants on promoter activity or protein structure (and/or function) may 
precipitate the disease phenotype (Devlin and Roeder 1999; Drysdale et al. 2000; Joosten 
et al. 2001).  A second reason stems from a mathematical finding.  It has been shown that 
case-control genetic association studies are most powerful when the genetic variant under 
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consideration possesses a frequency in the population identical to that of the disease 
mutation (Abel and Muller-Myhsok 1998; Tu and Whittemore 1999; Pfeiffer and Gail 
2003; Zondervan and Cardon 2004).  Therefore, if the frequency of a single haplotypic 
variant more closely matches the frequency of the disease mutation than the frequency of 
any allele at any of the marker loci comprising the haplotype, a haplotype-based 
association test should be more powerful than an allelic association test (Martin et al. 
2000; De La Vega et al. 2005).  However, haplotype-based association tests also present 
some disadvantages.  Techniques for directly observing haplotypes are expensive so more 
often haplotypes are inferred from multilocus genotypes using statistical methods.  Also, 
since haplotypes generally have a large number of genetic variants compared to 
genotypes or single alleles, haplotype-based association tests either possess more degrees 
of freedom or face a larger multiple testing problem than tests involving a single locus. 
 
1.2 Background for statistical tests 
Regardless of the genetic variant under investigation, several approaches can be 
taken to test for association.  One option relies on a 2 × s contingency table, where s is 
the total number of genetic variants, to record counts of the genetic information for cases 
and controls.  From the counts in the contingency table, a Pearson χ2 statistic, which 
compares the observed counts with those expected under the assumption of independence 
between case status and the genetic variant, can be computed (Pearson 1900; Agresti 
1996).   An alternative approach is to calculate the likelihood ratio test (LRT) statistic, 
which is twice the difference between the log-likelihood of the data under the assumption 
that an association exists (between case status and genetic variant) and the log-likelihood 
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of the data under the assumption that no association exists (Fisher 1922b; Fisher 1925; 
Edwards 1992).  When formulating the likelihood in terms of direct observations, such as 
genotypes, the multinomial distribution is used.  However, when formulating the 
likelihood in terms of a quantity with missing data, such as haplotypes, frequencies may 
be estimated from the Expectation-Maximization (EM) algorithm (Dempster et al. 1977) 
or other efficient methods and incorporated in the likelihood expression. 
Both the Pearson χ2 and the likelihood ratio approaches are examples of 
hypothesis testing involving two mutually exclusive hypotheses—the null hypothesis 
(H0) and the alternative hypothesis (H1).  The test evaluates the data available to 
determine whether sufficient evidence exists to reject the null hypothesis in favor of the 
alternative hypothesis.  For genetic association tests, the null hypothesis is that no 
association exists between the genetic variant and the disease state whereas the 
alternative hypothesis is that such an association does exist.  The general goal of a 
statistical test is to maximize power while controlling for type I error.  Power is the 
probability of a test yielding a positive result (i.e. rejecting the null hypothesis) when in 
fact the null hypothesis is false.  In other words, power represents a test’s ability to find 
true positives.  On the other hand, type I error (or the false positive rate) represents the 
probability that a test which rejects the null hypothesis will do so incorrectly.  Closely 
related to type I error, the statistical significance or p-value related to a test result 
represents the cumulative probability of achieving an equivalent or more extreme test 
result when H0 is true.  Prior to a single statistical test, type I error is set to a commonly 
accepted threshold (significance level) such as 0.05.  A test statistic with an associated p-
value less than this threshold results in rejecting H0 in favor of H1.  For example, if one 
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performs 100 tests on a population for which H0 is true using the 0.05 threshold for type I 
error, on average the results from five of the tests would lead to incorrectly rejecting H0. 
The statistical significance, or p-value, of a test result can be evaluated in several 
ways in the context of case-control association studies.  However, all approaches aim to 
determine the distribution of the test statistic under the null hypothesis and then use this 
distribution to compute the probability of achieving a test result (when the H0 is true) 
equivalent to or more extreme than the test result calculated from the data.  One approach 
relies on using a null distribution determined by classical statistics.  For instance, 
according to statistical theory under the null hypothesis of no association both the 
Pearson χ2 statistic and the LRT statistic follow a central χ2 distribution asymptotically 
for large sample sizes (Agresti 1996).  The number of degrees of freedom associated with 
the central χ2 distribution equals one less than the number of genetic variants present in 
the sample for the Pearson χ2 test and equals the difference between the number of free 
parameters estimated under H1 and H0 for the likelihood ratio test.  It has been shown that 
when Cochran’s rule is followed (more than five observations in each cell of the 
contingency table), this approach is reliable (Cochran 1952).  A second approach 
employs permutation testing to generate the distribution of the test statistic under the null 
hypothesis and to determine its statistical significance (Fisher 1935; Pitman 1937; Pitman 
1938).  In permutation testing, many null replicates of the original dataset are created by 
randomly reassigning case-control labels to the individuals in the study.  Then the test 
statistic is computed for each replicate dataset, and the distribution of these test statistics 
represents the distribution of the test statistic under the null hypothesis.  While this 
empirical approach provides extremely accurate p-values when a very large number of 
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permutations is used (regardless of the sample size), it is computationally intensive.  A 
third approach is Fisher’s exact test (Fisher 1922a) which employs the hypergeometric 
distribution to express the probability of contingency tables equivalent to and more 
extreme than the contingency table for the dataset.  Like the permutation approach, 
Fisher’s exact test produces accurate p-values even with extremely small sample sizes.  
However, large sample sizes or datasets associated with well-balanced tables can lead to 
difficulty in executing the test. 
Like computing statistical significance, there are multiple ways to determine the 
power of a test for genetic association.  In order to compute the power of a statistical test, 
one must know the distribution of the test statistic when the alternative hypothesis is true.  
In addition, the alternative hypothesis must be formulated in terms of parameters such 
that the power associated with given parameter values can be established.  Once the 
distribution is determined, one can compute the probability that a test statistic computed 
under H1 will be equivalent to or exceed the value of the test statistic associated with the 
type I error threshold.  One approach to finding this distribution relies on classical 
statistics.  For instance, according to statistical theory under the alternative hypothesis of 
association, both the Pearson χ2 statistic and the LRT statistic follow a noncentral χ2 
distribution asymptotically for large sample sizes (Mitra 1958; Hogg and Craig 1995; 
Agresti 1996).  This distribution is defined by two parameters—the degrees of freedom 
(df) and the noncentrality parameter (ncp).  While the degrees of freedom can be 
computed as described above in the discussion regarding statistical significance, the 
noncentrality parameter can be computed as a function of frequencies belonging to the 
genetic variants under investigation (in cases and controls separately), the number of 
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cases, and the number of controls (see http://linkage.rockefeller.edu/derek/pawe2.html) 
(Mitra 1958; Sham 1998; Gordon et al. 2002).  Once parameters defining the noncentral 
χ2 distribution are known explicitly, the power for a given significance level can be 
determined analytically.  Another approach for finding the distribution of the test statistic 
under the alternative hypothesis requires data simulation.  In this empirical approach, 
power is computed by generating thousands of datasets under a model where there is an 
association and finding the proportion of simulated datasets that produce a test statistic 
equivalent to or more extreme than the value of the test statistic associated with the type I 
error threshold.  For a very large number of generated datasets, simulation methods 
provide accurate power estimates; however, the cost of this accuracy is increased 
computational time. 
 
1.3 Multiple Testing 
Recall the example describing type I error in which 100 tests were performed on a 
population for which the null hypothesis is true using the 0.05 threshold for type I error.  
On average, the results from five of the tests would lead to incorrectly rejecting the null 
hypothesis.  A somewhat analogous situation arises when it is desirable to perform a 
family of tests on the same dataset.  This analogous situation complicates the 
interpretation of type I error.  When many tests are performed on the same dataset, each 
additional test provides another opportunity for a spurious positive result.  Consequently, 
the probability of at least one of the tests yielding a false positive result is higher than the 
type I error threshold employed for each individual test.  To protect against this 
phenomenon, classical comparison procedures strive to control the family-wise error rate 
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(FWER) or the probability of incorrectly rejecting any null hypothesis in a group of tests 
under simultaneous consideration. 
Several statistical methods have been developed to control the FWER.  These 
methods can be classified as single-step methods and stepwise methods (Westfall and 
Young 1993).  For single-step methods, such as the Bonferroni correction and the Šidák 
method (Šidák 1967), equivalent multiplicity adjustments are applied to the p-values for 
all tests, regardless of the ordering of the observed p-values.  Since the Bonferroni and 
Šidák methods assume that the tests are independent of one another, they can be 
conservative when this assumption is false.  In contrast, stepwise methods, such as step-
up and step-down procedures, permit different adjustments for different tests depending 
on the ordering of the observed p-values (Westfall and Young 1993).  In recent years, 
improved computing technology has facilitated the use of resampling methods, such as 
bootstrapping, Monte Carlo simulations, and permutation resampling.  Specifically, 
Westfall and Young have contributed several resampling methods for multiple testing 
(Westfall and Young 1993).  While these methods are attractive in that they often can 
effectively capture the correlation structure of the tests and allow for increased power, 
they may be computationally expensive. 
More recently, procedures have been developed which control the false discovery 
rate (FDR) rather than the FWER (Benjamini and Hochberg 1995).  Such procedures aim 
to ensure that on average the proportion of false positives among all positive results is 
within an acceptable limit.  Only for cases where the number of true null hypotheses 
equals the total number of hypotheses examined are the FDR and the FWER criteria 
equivalent.  Otherwise, as more null hypotheses are false, the FDR becomes smaller.  
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Thus, procedures that control the FDR often have greater power than classical multiple 
comparison procedures aimed at controlling the FWER (Benjamini and Hochberg 1995).  
These procedures seem promising and may prove to offer an advantage over the current 
practices. 
In the search for susceptibility genes for human disease, multiple testing has 
posed a formidable obstacle.  Over the last two decades, the discovery of new varieties of 
polymorphic genetic markers has aided the effort to localize disease genes.  With 
Restriction Fragment Polymorphisms (RFLPs), Variable Number of Tandem Repeat 
(VNTR) markers, microsatellite markers, and SNPs, researchers have millions of markers 
at their disposal and continue to discover more (Sachidanandam et al. 2001; Venter et al. 
2001).  As a result, researchers perform tests of linkage and association for large numbers 
of haplotypes, alleles, or genotypes at regular intervals across entire chromosomes or 
genomes (Risch and Merikangas 1996).  Although this comprehensive approach 
improves the likelihood of testing in an area of the genome where true linkage or linkage 
disequilibrium (LD) exists, it requires a multiplicity of testing—one test (or more) at each 
marker.  To control the false positive rate, appropriate genome-wide LOD score 
thresholds have been created for tests of linkage under both homogeneity and 
heterogeneity (Morton 1955; Terwilliger and Ott 1994; Lander and Kruglyak 1995; 
Huang and Vieland 2001).  In addition, to adjust for multiple testing for other tests, such 
as association tests, the Affected Sib Pair Test (ASP), and the Transmission 
Disequilibrium Test (TDT), researchers apply other forms of correction to p-values 
(Lander and Kruglyak 1995; Miller 1997).  Over the past few years, procedures which 
control the FDR have been applied to genetic mapping (Weller et al. 1998; Devlin et al. 
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2003; Sabatti et al. 2003) and the analysis of differential gene expression (Storey and 
Tibshirani 2001; Reiner et al. 2003; Yang et al. 2003).   In spite of the difficulties 
imposed by multiple comparisons, genome-wide testing has successfully localized many 
Mendelian disorders (Gusella et al. 1983; Kerem et al. 1989; Saunders et al. 1993).  
However, prominent medical conditions, such as diabetes, heart disease, schizophrenia, 
and bipolar disorder, appear not to follow Mendelian patterns of inheritance but rather 
involve interactions with the environment and/or other genes.  In these situations, 
adjusting for multiple testing severely compromises the power of the test since testing for 
main effects and interactions across the genome results in an unwieldy number of 
comparisons (Dupuis et al. 1995). 
 
1.4 Hierarchical Clustering 
In addition to the multiple testing issues mentioned above, other methods 
employed to organize genetic marker data also introduce a multiplicity of testing.  
Hierarchical (agglomerative) clustering is an information theoretical method that 
sequentially merges samples based on the pair-wise similarity of a given measurement to 
form common groups until all samples are contained in a single group (Hastie et al. 
2001).  The method has many applications and is widely used in the analysis of biological 
data.  For example, researchers testing for association between haplotypes and disease 
have employed hierarchical clustering as a means to reduce a large number of haplotypes 
to a manageable number of haplotype classes with the aim to increase statistical power 
(Hoehe et al. 2000).  With an increasing number of marker loci, the number of possible 
haplotypes grows exponentially so that many of these haplotypes tend to have low 
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frequency.  This situation is relatively common when examining haplotypes within 
candidate genes because of the availability of dense SNP marker maps, in which the 
spacing between markers often is less than one kilobase (Sachidanandam et al. 2001).  In 
comparisons of haplotype frequencies between case and control individuals, the 
corresponding contingency tables are therefore often sparse and difficult to interpret.  
Hierarchical clustering then allows researchers to merge haplotypes into classes that are 
easier to handle.  At each step within the hierarchy, either implicitly or explicitly, 
researchers tend to interpret results and eventually focus on that set of classes providing 
the most significant result.  Testing at each of the different clustering steps within a 
hierarchical structure also represents a form of multiple comparisons; therefore, the 
minimum p-value evaluated over many steps is too small to represent the experiment-
wise significance level. 
Many methods, including hierarchical clustering, can be applied to partition a 
dataset into subgroups whose elements share common characteristics.  Several methods 
of non-hierarchical clustering or partitional clustering exist.  Some common partitional 
methods include k-means clustering (MacQueen 1967), quality threshold (QT) clustering 
(Heyer et al. 1999), and fuzzy clustering (Dunn 1973).  In addition, hierarchical 
clustering has two varieties—1) agglomerative (bottom-up) clustering in which the 
groups are built up at each progressive stage of clustering so that each item starts in its 
own group and 2) divisive (top-down) clustering in which a single group exists initially 
and items are removed as clustering progresses.  Once a hierarchical clustering procedure 
constructs a dendrogram or tree diagram representing the grouping structure, the dataset 
can be divided into any number of groups by selecting the appropriate clustering stage or 
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level.  In order to construct the grouping structure, the procedures must define the 
distance between groups.  One option, single linkage, defines the distance between two 
groups as the minimum pair-wise distance between any item in the first group and any 
item in the second group whereas another option, complete linkage, finds distance as the 
maximum pair-wise distance between any item in the first group and any item in the 
second group.  A third option, average linkage, uses the average of all pair-wise distances 
between items in the two groups (Johnson 1967).  In addition, there are several metrics 
for determining pair-wise distance between individual items.  Common distance metrics 
include Euclidean distance, squared Euclidean distance, Manhattan distance, and the 
correlation coefficient. 
 
1.5 Estimation, inference, and haplotype-based association 
Methods which apply techniques, such as allele-specific long-range PCR and 
somatic cell hybrid construction, from molecular biology for explicit determination of 
phased haplotypes are available (Papadopoulos et al. 1995; Michalatos-Beloin et al. 
1996; Clark et al. 1998; Yan et al. 2000; Douglas et al. 2001; Patil et al. 2001; Burgtorf et 
al. 2003; Ding and Cantor 2003; Horan et al. 2003; Hoppe et al. 2004; Proudnikov et al. 
2004; Yu et al. 2004; Hoppe et al. 2006; Proudnikov et al. 2006).  However, because 
current molecular haplotyping methods are expensive and not amenable to automation, in 
practice phased haplotypes are rarely determined explicitly.  Instead, statistical methods 
for gene mapping estimate haplotype frequencies from multilocus genotype data and 
often provide haplotype assignments or calls for individuals (Clark 1990; Xie and Ott 
1993; Terwilliger and Ott 1994; Excoffier and Slatkin 1995; Hawley and Kidd 1995; 
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Long et al. 1995; Zhao et al. 2000; Stephens et al. 2001b; Zhao and Sham 2002; Stephens 
and Donnelly 2003).   Since the parental origins of the two alleles comprising any single 
genotype are not directly observed, constructing phased haplotypes from multilocus 
genotypes can be complicated.  Consider two SNP marker loci where A and a represent 
the alleles at the first locus while B and b represent the alleles at the second locus.  One 
can assign haplotype pairs unequivocally for all possible multilocus genotypes except for 
the double heterozygote AaBb.  For instance, the multilocus genotype AaBB, must derive 
from the haplotype pair AB and aB.  In contrast, the multilocus genotype AaBb either 
derives from the haplotype pair AB and ab or the haplotype pair Ab and aB.  Such 
ambiguous cases occur for any multilocus genotype possessing two or more loci with a 
heterozygote.  As with fine mapping in linkage studies, knowledge of the parental 
genotypes can greatly simplify the problem of phasing.  However, for case-control 
association studies, the sampling design involves unrelated individuals, and, 
consequently, parental genotypes are rarely collected.  Therefore, the procedure utilized 
to estimate haplotype frequencies treats each individual as an independent observation.   
Several methods have been developed to estimate haplotype frequencies for non-
familial study designs.  While the first method developed for haplotype estimation is 
based on the principle of maximum parsimony (Clark 1990; Wang and Xu 2003), 
methods that rely on the Expectation-Maximization (EM) algorithm (Dempster et al. 
1977) for a likelihood approach (Xie and Ott 1993; Excoffier and Slatkin 1995; Hawley 
and Kidd 1995; Long et al. 1995) or use a Bayesian approach applying a prior based on 
coalescence theory (Stephens et al. 2001b; Stephens and Donnelly 2003) or a Dirichlet 
prior (Niu et al. 2002) are more commonly used.  Although it is a relatively 
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straightforward method, Clark’s method has several disadvantages among which are its 
inability to provide unique solutions and its sensitivity to deviations from HWE (Niu et 
al. 2002; Niu 2004).  In contrast, the EM algorithm-based and Bayesian approaches have 
been shown to be relatively robust to such deviations (in spite of the fact that the EM 
algorithm-based approaches assume HWE) (Niu et al. 2002; Niu 2004).   Each of these 
approaches has been implemented in statistical software.  Specifically, the parsimony-
based methods are implemented in HAPINFERX and HAPAR (Wang and Xu 2003); the 
EM algorithm-based methods are implemented in SNPHAP (see Electronic Resource 
Information), HAPLO (Hawley and Kidd 1995), and PL-EM (Qin et al. 2002); and the 
Bayesian approaches are implemented in PHASE (Stephens et al. 2001b) (see Electronic 
Resource Information) and HAPLOTYPER (Niu et al. 2002). 
As with other procedures for statistical estimation, the accuracy of haplotype 
frequency estimates depends on several factors including “sample size, number of loci 
studied, allele frequencies, and locus-specific allelic departures from Hardy-Weinberg 
and linkage equilibrium” (Fallin and Schork 2000).  Furthermore, these factors also affect 
the accuracy of phased haplotype inference or phased haplotype calls (Niu 2004).  
Several researchers have investigated the accuracy of haplotype inference procedures by 
applying them to real and simulated data sets (Tishkoff et al. 2000; Clark et al. 2001; Xu 
et al. 2002; Stephens and Donnelly 2003; Adkins 2004; Kang et al. 2004; Niu 2004; Xu 
et al. 2004; Heid et al. 2005; Sabbagh and Darlu 2005; Zhang et al. 2005; Marchini et al. 
2006; Proudnikov et al. 2006).  In addition, Douglas et al. found molecular haplotyping 
provided large efficiency advantages over haplotype inference from multilocus genotypes 
under the condition of linkage equilibrium between marker loci (Douglas et al. 2001).   
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Using simulation studies, Schaid extended the work of Douglas et al. to conditions with 
linkage disequibrium between the markers.  The studies found that the advantage of 
molecular haplotyping over haplotype inference decreased with increasing LD (Schaid 
2002).   Similar studies have investigated the power advantage of molecular haplotyping 
over haplotype estimation techniques for genetic association studies (O'Hely and Slatkin 
2003; Thomas et al. 2004). 
As described earlier, multiple statistical methods, such as the Pearson χ2 test and 
the likelihood ratio test, are available to perform tests of case-control association.  
However, since the original observations (multilocus genotypes) lack phase information, 
the testing situation is a bit more complex.  This additional complexity results in issues 
unique to tests of haplotype-based association as compared with other genetic association 
tests.  In accord with the earlier description, the likelihood ratio test for haplotype-based 
association involves calculating the likelihood of the data in terms of the estimated 
haplotype frequencies (Xie and Ott 1993; Fallin et al. 2001).  However, some haplotypic 
variants may be estimated to have a small frequency despite the fact that none of the 
study participants comprising the sample possess them.  The effect of this situation on the 
distribution of the resulting test statistic under both null and alternative hypotheses 
remains unclear.  One still expects that the test statistic will follow a central χ2 
distribution under H0 and a noncentral χ2 distribution under H1.  However, the degrees of 
freedom associated with either χ2 distribution are no longer well defined.   
Also analogous to the earlier discussion, an alternative method for haplotype-
based association relies on the use of a contingency table containing the case-control 
counts for each inferred haplotype.  The counts in the contingency table can be 
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determined either by inferring phased haplotypes for each individual or by multiplying 
each haplotype frequency estimate by the total number of haplotypes in the study.  With 
data in the completed contingency table, either a Pearson χ2 test or a likelihood ratio test 
can be performed.  Many researchers find this second method with the contingency table 
appealing since it applies the same format as classic genotypic and allelic case-control 
studies and explicitly accounts for each phased haplotype.  As a result, many researchers 
employ this method in practice (Hoehe et al. 2000; Maksymowych et al. 2003; Xu et al. 
2004; Hindorff et al. 2006; Proudnikov et al. 2006).  In the event that all phased 
haplotypes have been called correctly, this method can provide additional power (Cox 
and Hinkley 1974; Little and Rubin 1987).   This situation is analogous to tests of 
association using allele estimates from individual genotypes as compared with allele 
frequency estimates from DNA-pooling data (Johnson et al. 2001). 
However, misclassifications can lower a study’s power and/or affect the false 
positive rate.  The act of calling haplotype pairs from multilocus genotypes in the phase 
ambiguous situation is similar to the act of dichotomizing continuous measures.  Royston 
et al. document a loss in power when dichotomizing continuous predictor variables in a 
regression analysis (Royston et al. 2006).  In the context of a haplotype-based association 
study utilizing the contingency table design, a misclassification results when the 
haplotype pair called for an individual is not the true underlying haplotype pair.  Non-
differential misclassification occurs when the misclassification rates are the same in cases 
and controls.  When non-differential misclassification exists, the test suffers a loss in 
power but the false positive rate remains unchanged (Mote and Anderson 1965; Gordon 
et al. 2002).  In contrast, differential misclassification inflates the test’s false positive rate 
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and may diminish its power (Clayton et al. 2005).  In addition to errors due to the 
statistical procedure, misclassification of the multilocus genotypes will lead to miscalling 
haplotype pairs.  In the absence of differential genotype misclassification, all haplotype 
misclassification should be non-differential when haplotype frequency distributions are 
the same in cases and controls, i.e. under the null hypothesis. 
This thesis addresses several of the challenges currently confronting investigators 
conducting haplotype-based association studies.  Chapter 2 examines the multiple testing 
problem that results from applying a hierarchical clustering procedure to haplotypes and 
then performing a statistical test for association at each of the steps in the resulting 
hierarchy.  The proposed approach to overcome this challenge is creating an experiment-
wise statistic of interest and finding its significance.  Chapter 3 explores the 
consequences of the errors present when haplotype prediction programs are employed to 
assign haplotype pairs for each individual in commonly used tests of haplotype-based 
association.  While there have been several studies aimed at evaluating the accuracy of 
haplotype inference and haplotype frequency estimation procedures (Fallin and Schork 
2000; Tishkoff et al. 2000; Clark et al. 2001; Xu et al. 2002; Stephens and Donnelly 
2003; Niu 2004; Xu et al. 2004; Sabbagh and Darlu 2005; Marchini et al. 2006), no 
systematic study has documented the effects of haplotype misclassification on the false 
positive rate and power.  In this chapter, we compare the performance of a test statistic 
that utilizes a double-sampling procedure to account for haplotype misclassification with 
the standard likelihood ratio test statistic.  Chapter 4 investigates the uncertainty 
regarding the exact distribution of the likelihood ratio statistic under the null hypothesis 
of no association for haplotype-based association tests in which many of the haplotype 
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frequency estimates are zero or very small.  In this chapter, we characterize the 
distribution of the LRT statistic by simulating null datasets with known haplotype 
frequencies and comparing the empirical distribution with various theoretical 
distributions.  Finally, chapter 5 draws some conclusions from these studies and discusses 
future directions for research related to haplotype-based association. 
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New techniques in the biological sciences, like high throughput genotyping, 
microarray chip assays, and an explosion of online databases, have created a wealth of 
information regarding biological systems.  The burgeoning discipline of bioinformatics 
illustrates the need for data organization and the development of statistically sound 
methods for analysis.  An increasingly common issue for a variety of applications in 
biology is the artificial inflation of statistical significance associated with multiple 
testing. 
With the increasing amount of data generated in molecular genetics laboratories, 
it is often difficult to make sense of results because of the vast number of different 
outcomes or variables studied.  Examples include haplotypes comprised of large numbers 
of loci and expression levels for large numbers of genes.  It is then natural to group 
observations into smaller numbers of classes that allow for an easier overview and 
interpretation of the data.  This grouping is often carried out in multiple steps with the aid 
of hierarchical cluster analysis, each step leading to a smaller number of classes by 
combining similar observations or classes.   
For example, researchers testing for association between haplotypes and disease 
have employed hierarchical clustering to reduce a large number of haplotypes to a 
manageable number of haplotype classes with the aim to increase statistical power 
(Hoehe et al. 2000).  With an increasing number of marker loci, the number of possible 
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haplotypes grows exponentially so that many of these haplotypes tend to have low 
frequency.  In comparisons of haplotype frequencies between case and control 
individuals, the corresponding contingency tables are often sparse and difficult to 
interpret.  Several strategies, such as pooling the rarest categories to form a single 
haplotype class (Sham and Curtis 1995; Schaid et al. 2002; Zhao et al. 2003) and using 
haplotype diversity criteria for SNP selection (Johnson et al. 2001; Jannot et al. 2004) 
(http://www-gene.cimr.cam.ac.uk/clayton/software/stata/htSNP/htsnp.pdf), have been 
suggested to reduce the number of classes. Unlike these alternatives, hierarchical 
clustering allows researchers to merge haplotypes, based on sequence similarities, into 
classes that are easier to handle.  Initially, each haplotype is considered to be its own 
class.  With each step in the clustering process, haplotype classes are merged based on 
the pair-wise similarity of the allele sequences comprising the haplotypes contained 
within each class until all samples are contained in a single haplotype class.  At each step 
in the resulting hierarchy, either implicitly or explicitly, researchers tend to interpret 
results and eventually focus on the set of classes providing the “best” (most significant) 
result.  While this approach makes sense, the overall statistical significance of the 
experiment must include the clustering process, which modifies the grouping structure of 
the data. 
Another example of hierarchical clustering is its application in microarray 
analyses (Eisen et al. 1998; Alon et al. 1999; Gasch et al. 2000).  Often clustering of 
arrays based on microarray expression data is utilized to distinguish tumor subclasses, 
which have clinical implications (Golub et al. 1999; Chung et al. 2002).  In many of these 
studies involving microarray expression data from tumor specimens, researchers are 
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interested in examining survival information for the subjects who contributed the samples 
and comparing the survival curves between groups formed by the hierarchical clustering 
procedure (Alizadeh et al. 2000; Bhattacharjee et al. 2001; Garber et al. 2001; Sorlie et al. 
2001; Guo et al. 2006; Perreard et al. 2006).  After performing cluster analysis on the 
expression data, researchers tend to concentrate their attention on the step in the resulting 
hierarchy with the most striking difference in survival between patient groups and 
evaluate this result without taking into account the grouping structure at the other steps.   
Here we propose an analysis method that properly takes the process of clustering 
into account.  We achieve this by defining the strongest result or, equivalently, the 
smallest p-value, occurring in the course of clustering as the statistic of interest and 
computing its associated (experiment-wise) empirical significance level.  The methods 
developed in this chapter will be applied to three previously published datasets in which 
hierarchical clustering has been employed.  One of these datasets involves a haplotype-
based association analysis while the other two datasets refer to survival analyses of 
groups of individuals determined by microarray expression measurements. 
The problem of testing group differences sequentially is in the framework of 
multiple testing.  Historically, both genetic association studies and microarray studies 
have been plagued with multiple testing problems.  In the case of association studies, 
multiple testing occurs because researchers perform tests of association for large numbers 
of haplotypes, alleles, or genotypes across entire chromosomes or genomes (Risch and 
Merikangas 1996).  In the case of microarray data analysis, researchers sequentially test 
thousands of genes for differential expression.  Testing at each of the different clustering 
steps within a hierarchical structure also represents a form of multiple comparisons; 
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therefore, the experiment-wise type I error is inflated.  Various correction methods such 
as Bonferroni, step-up, and step-down have been employed to adjust for the multiplicity 
of testing (Reiner et al. 2003).  These procedures appear to work well only when the tests 
in the sequence are independent or weakly correlated.  Since the tests within the 
hierarchy possess a nested structure, these procedures are inappropriate for our situation.  
As mentioned above, here we propose an alternative solution by defining a single test 
statistic, for which we evaluate the experiment-wise statistical significance. 
 
2.2 Methods 
Local p-values.  Consider multiple steps in hierarchical clustering.  For each of n 
steps of the hierarchy, we calculate our statistic of interest depending on the application.  
In the case of haplotype-based association tests, we compute the Pearson χ2 (Agresti 
1996) for a 2 × s contingency table (case/control individuals versus s haplotypes or 
haplotype classes) while, in the case of survival analyses, we compute the log-rank 
statistic (Kalbfleisch and Prentice 1980).  We represent these statistics as a 
vector,  where X),,...,,( 21 nXXXX =
r
i represents the statistic obtained at the ith step in the 
clustering process.  To make statistics from different applications comparable, we 
compute the empirical significance level, pi, associated with Xi and call this a local p-
value.   
We approximate these local empirical significance levels via permutation 
analysis.  These permutation methods involve randomly permuting labels for each 
individual as follows.  For haplotype-based association tests, we permute the case/control 
labels (Zhao et al. 2000; Zhao and Sham 2002) while for survival analyses, we permute 
 27
failure times and censorship statuses jointly.  For each permutation of the dataset, we 
cluster the permuted samples as illustrated by the dendrogram and calculate a null 
statistic based on the permuted samples at each step in order to generate the null 
distribution for the statistic.  We can represent the collection of null statistics calculated 

























where the entry appearing in the ith row and the jth column, Xij, is the statistic of interest 
computed from the ith permutation of the data at the jth step in the hierarchy.  At each step 
of the hierarchy, by comparing the statistic we computed from the data with the null 
statistics we computed from the m permutations, we calculate a local p-value, pj, as the 
proportion of permutation samples with a null statistic at least as large as the observed 
statistic.  That is, the local p-value, pj, is the proportion of null statistics in the jth column 
of Xnull that are greater than or equal to the statistic, Xi, calculated from the data at the jth 
step in the hierarchy.  We represent the local p-values as the vector,  ).,...,,( 21 npppp =
r
Permutation (randomization) samples allow one to conveniently approximate the 
sampling distribution of test statistics under the null hypothesis (the “null distribution”).  
Ideally, permutation tests are based on the total of all permutations but in practice we 
usually can only collect a random sample from these permutations.  The number m of 
permutation samples should be large enough to adequately represent the sample space of 
permutations.  For the haplotype data (example 1), at each step we compared 
approximated p-values obtained with different values of m to exact p-values calculated 
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using the statistical software package StatXact 5 (see Electronic Resource Information).  
For the first few steps in the hierarchy, values of m on the order of 10,000 were sufficient 
to provide p-values very close to the correct ones.  However, at later steps, agreement 
was only obtained with m = 100,000, presumably because at early steps the total number 
of permutations is much smaller than at later steps.  Table 2.1 displays the local p-values 
for example 1 computed both with our method using 100,000 permutation samples and 
with Pearson’s exact test as implemented in StatXact 5.  The calculations for the two 
survival analyses (examples 2 and 3) were also performed with m = 100,000. 
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Table 2.1  Comparison of local p-values computed using our method with p-values 
computed using exact tests 
Step  Local p-Value 95% C.I. Exact Test p-Value
0 0.5275 (0.5244, 0.5306) 0.5270 
1 0.4736 (0.4705, 0.4767) 0.4739 
2 0.4710 (0.4679, 0.4741) 0.4718 
3 0.3533 (0.3503, 0.3563) 0.3532 
4 0.3930 (0.3900, 0.3960) 0.3928 
5 0.2844 (0.2816, 0.2872) 0.2825 
6 0.2726 (0.2700, 0.2754) 0.2706 
7 0.2229 (0.2203, 0.2255) 0.2205 
8 0.1502 (0.1480, 0.1524) 0.1501 
9 0.1282 (0.1261, 0.1303) 0.1289 
10 0.1166 (0.1146, 0.1186) 0.1165 
11 0.0929 (0.0911, 0.0947) 0.0929 
12 0.0668 (0.0653, 0.0684) 0.0674 
13 0.0425 (0.0413, 0.0438) 0.0433 
14 0.0292 (0.0282, 0.0303) 0.0298 
15 0.1659 (0.1636, 0.1682) 0.1659 
16 0.2362 (0.2336, 0.2388) 0.2379 
17 0.1486 (0.1464, 0.1508) 0.1500 
18 0.1089 (0.1070, 0.1108) 0.1099 
19 0.0477 (0.0464, 0.0490) 0.0482 
20 0.0424 (0.0412, 0.0437) 0.0423 
 
Legend for Table 2.1: This table displays the local p-values computed for example 1 using both 
our method with 100,000 permutation samples and Pearson’s exact test as implemented in 
StatXact 5.  In addition, the table provides the 95% confidence interval for the p-value estimates 
computed by our method.  The zeroth step refers to the data before any clustering is performed.  
For the test at the zeroth step, the Monte Carlo method (500,000 tables sampled) in StatXact 5 
was employed to find the p-value since the problem was too large for the exact test. 
 
Global p-value.  In order to gain an empirical significance assessment for the 
entire experiment, we define a single statistic, that is, the smallest of the local p-
values,  (Hoh et al. 2001).  To assess the empirical significance level (global p-)(min ii p
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value), pmin, associated with this statistic we generate the null distribution 
of from the matrix of null statistics, X)(min ii p null.  In this matrix, we consider each row 
(replicate dataset) in turn as observed data and evaluate these data based on the remaining 
m – 1 null data as described above for m null data.  That is, for each of these “null 
observed” permutation samples a minimum p-value is obtained at whatever step it occurs.  
This leads to a set of m null values for .  The proportion of these values at least 
as small as the observed represents the global significance level, p
)(min ii p
)(min ii p min, associated 
with our single experiment-wise statistic.  Since this approach requires that the p-values 
be ordered, starting with the most significant, it could be considered a step-down p-value 
adjustment procedure similar to the procedure developed by Westfall and Young 
(Westfall and Young 1993).  If pmin ≤ 0.05 then we say that the experiment (at least one 
of the steps in the clustering process) is significant at the 5% level.   
It is also of interest to compare the global p-value with the significance level, p0, 
of the association or log-rank statistic before clustering since clustering is only beneficial 
when pmin < p0.  It may well happen that the smallest p-value, , at one of the 
steps in the course of clustering is smaller than p
)(min ii p
0 but the clustering process is such that 
this smallest p-value has a high probability of occurring by chance.  In that case, one will 
find that pmin > p0.  For example, observing a minimum p-value smaller than 0.05 and 
interpreting it as significant is fallacious when this small p-value is easily obtained with 
probability pmin > 0.05. 
 
Statistics of interest. As mentioned above, in the case of association studies 
between haplotypes and disease we employ the Pearson χ2 to test each step of the 
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hierarchy for association (Agresti 1996).  However, in the case of survival analyses, our 
statistic of interest is the log-rank statistic (Kalbfleisch and Prentice 1980).  It provides an 
overall comparison of the Kaplan-Meier survival curves for two or more groups of 
subjects.  For r groups, the log-rank statistic asymptotically follows a central χ2 
distribution with r – 1 degrees of freedom under the null hypothesis of equality of 
survival curves. 
 
Validation of the algorithm.  In order to validate this method, we analyzed 
several datasets with a strategy nearly identical to the one described above.  The only 
difference was that this second strategy relies on the theoretical χ2 distribution to 
determine the local p-values.  Since the use of the theoretical χ2 distribution for finding 
statistical significance is valid only for non-sparse datasets, we analyzed several non-
sparse datasets with both procedures and compared the results. 
In addition, we validated our method using an analytical approach.  Suppose we 
have n steps in the hierarchy formed by clustering, and a test is performed at each step.  
Then under the null hypothesis, local p-values at all steps of clustering are standard 
uniform random variables.  We can express the global p-value as  
( ) ( ){ }obsiinullii pp minminPr ≤     (2.1) 
or the probability that value for the minimum of the local p-values from data under the 
null hypothesis, , is less than or equal to the value of the minimum of the 
local p-values from the observed data, min .  Applying a basic axiom of 
probability involving complementary events (Ross 2002), we can alter expression (2.1) to 






{ }obsiinobsiiobsii pppppp )(min,,)(min,)(minPr1 21 >>>− K .  (2.2) 
Under the assumption of independence, this expression simplifies to the Bonferroni 
correction.  However, since the tests are correlated due to the nested structure of the 
hierarchy, we must pursue an alternate approach.  We would like to use the correlation 
structure between steps to determine this joint probability.  Although the multivariate 
uniform distribution from which the null local p-values are derived does not have a one to 
one correspondence between the correlation structure and the probability density function 
(pdf), the multivariate normal distribution does have this property.  We apply the inverse 
normal cumulative density function (cdf) to transform the null local p-values from 
standard uniform random variables to a multivariate normal distribution with variance-
covariance matrix, V, and mean vector, u .  We uniquely define the multivariate normal 
distribution by setting u  to be a vector composed entirely of 0 values and using the 
transformed local p-values to estimate V.  Thus, after the transformation of variables, we 
can rewrite expression (2.2) as 
( ) ( ) ( ){ }obsiinobsiiobsii pYpYpY )(min,,)(min,)(minPr1 11211 −−− Φ>Φ>Φ>− K ,       (2.3) 
where each Yi is the transformed null local p-value at the ith step and Φ  is the inverse 
standard normal cdf.  Because of symmetry, the expression becomes  
1−
( ) ( ) ( ){ }obsiinobsiiobsii pYpYpY )(min,,)(min,)(minPr1 11211 −−− Φ−<−Φ−<−Φ−<−− K .(2.4)
Since -Yi also follows a multivariate normal distribution with V and u , the quantity can 
be expressed as a function of the cdf of this multivariate normal distribution as in 
expression (2.5). 
( ) ( ) ( )[ ]obsiiobsiiobsii ppp )(min,,)(min,)(mincdf1 111 −−− Φ−Φ−Φ−− K            (2.5) 
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With this analytical approach, we examined two datasets—one consisting of two 
steps as a result of clustering (calibration) and another consisting of nine steps as a result 
of clustering (analysis).  Table 2.2 and Table 2.3 display the contingency tables at each 
step of clustering for the two-step and nine-step datasets, respectively.  For both datasets, 
we used Mathematica v.4.2 to compute the cdf in expression (2.5).  In our estimate of V, 
the diagonal elements were rounded to the value 1.  For the two-step dataset, we found an 
explicit value for the global p-value using the analytical method.  For the nine-step 
dataset, we were unable to analytically determine an explicit value for the global p-value 
due to limitations of software.  Instead, we established an upper and a lower bound by 
applying the analytical approach twice—once using the minimum pair-wise covariance 
estimate for all off-diagonal elements of V and a second time using the maximum pair-
wise estimate for all off-diagonal elements of V.  Thus, the first calculation, assuming the 
minimum correlation structure, provides a lower bound while the second calculation, 
assuming the maximum correlation structure, provides an upper bound.  We compared 
the results applying the analytical approach with those from our original algorithm for 
determining pmin.  For the validation, we used 10,000 permutation datasets. 
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Table 2.2  Contingency tables for two-step dataset used for method validation 
Step Group Number of Cases 
Number of 
Controls 
Group 1 32 18 
Group 2 24 16 0 
Group 3 20 30 
Group 1 56 34 1 
Group 2 20 30 
 
Legend for Table 2.2: This collection of contingency tables displays the case-control counts for 
the haplotype classes present at each of the two steps of clustering for a dataset used to validate 
the method employed to find the global p-value.  The zeroth step refers to the data before any 
clustering is performed. 
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Table 2.3  Contingency tables for nine-step dataset used for method validation 
Step Group Number of Cases 
Number of 





Group 1 10 10 Group 1 10 10 
Group 2 7 8 Group 2 7 8 
Group 3 11 14 Group 3 11 14 
Group 4 6 9 Group 4 6 9 
Group 5 12 13 Group 5 18 22 
Group 6 6 9 Group 6 25 20 
Group 7 17 13 
3 
Group 7 23 17 
Group 8 8 7 Group 1 10 10 
Group 9 11 9 Group 2 7 8 
0 
Group 10 12 8 Group 3 17 23 
Group 1 10 10 Group 4 18 22 
Group 2 7 8 Group 5 25 20 
Group 3 11 14 
4 
Group 6 23 17 
Group 4 6 9 Group 1 17 18 
Group 5 12 13 Group 2 17 23 
Group 6 6 9 Group 3 18 22 
Group 7 17 13 Group 4 25 20 
Group 8 8 7 
5 
Group 5 23 17 
1 
Group 9 23 17 Group 1 17 18 
Group 1 10 10 Group 2 17 23 
Group 2 7 8 Group 3 18 22 
Group 3 11 14 
6 
Group 4 48 37 
Group 4 6 9 Group 1 17 18 
Group 5 12 13 Group 2 35 45 
Group 6 6 9 
7 
Group 3 48 37 
Group 7 25 20 Group 1 52 63 
2 
Group 8 23 17  
8 
Group 2 48 37 
 
Legend for Table 2.3: This collection of contingency tables displays case-control counts for the 
haplotype classes present at each of the nine steps of clustering for a dataset used to validate the 
method employed to find the global p-value.  The zeroth step refers to the data before any 
clustering is performed. 
 
2.3 Results 
To demonstrate our approach on real data, we reanalyze the following three 
previously published datasets. 
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Example 1 (haplotype data).  The first dataset consists of 52 statistically 
predicted haplotypes in 172 African-American study participants (137 case and 35 
control individuals) (Hoehe et al. 2000).  The aim of that case-control study was to test 
for association between haplotypes at 25 single-nucleotide polymorphism (SNP) loci in 
the human µ opioid receptor gene (OPRM1) and substance dependence.  The large 
number of haplotypes was difficult to interpret and appeared to create a situation with 
insufficient power to detect association.  Thus, hierarchical clustering was applied to the 
52 haplotypes.  These were sequentially grouped according to the procedure CLUSTER 
(method = BAVERAGE, measure = SEUCLID) from the SPSS software package for 
Windows (Hoehe et al. 2000).  For each step of the resulting dendrogram shown by 
Figure 2.1, the hierarchical clustering procedure designates which haplotypes are 
clustered to form haplotype classes.  At each step of the hierarchy an association test was 
performed between haplotype classes and disease status.  As the clustering progressed, 
the number of classes became smaller and smaller. 
Using the same clustering methods and resulting hierarchical structure, we apply 
our algorithm for assessing local and global p-values in this dataset.  Our p-values differ 
somewhat from the ones previously published (Hoehe et al. 2000) but the patterns of the 
local p-values across the clustering steps shown in Figure 2.2 and in the publication by 
Hoehe et al. (Hoehe et al. 2000), respectively, are highly comparable.  Based on 
m = 100,000 permutation samples (see section 2.2), we calculate local p-values for 
hierarchical clustering steps zero through 20, where zero represents the step with un-
clustered haplotypes and 20 represents the step where only two haplotype groups remain.  
We find the smallest p-value, = 0.0292, at step 14 (Figure 2.2).  Thus, one is )(min ii p
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tempted to declare this result borderline significant at the 5% level.  However, the 
(global) significance level associated with this smallest p-value turns out to be 
pmin = 0.1328, that is, there is more than a 13% random chance (unrelated to association 
between haplotypes and disease) to find at any step in the hierarchy a minimum p-value 
at least as small as the value of 0.0292 found for the observed data.  This result leaves the 
experiment statistically non-significant.  Since clustering produced an experiment-wise 
significance level of pmin less than the initial pre-clustering significance level of 
p0 = 0.5275, the clustering process did provide a benefit for this dataset (even though the 
results from clustering were not statistically significant). 
 
Figure 2.1  Dendrogram created by clustering data from Hoehe et al. (Hoehe et al. 2000) 
 
Legend for Figure 2.1:  This schematized dendrogram reflects the process of clustering case-
control observations based on the similarity of haplotype data as measured by the squared 
Euclidean distance.  Distances between haplotype classes are approximated (not to scale) by the 
vertical axis.  Along the bottom of the dendrogram are the identification numbers for the inferred 
haplotypes as described by Hoehe et al. (Hoehe et al. 2000). 
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Figure 2.2  Results from haplotype-based association tests applied to all steps of the 

















































































Legend for Figure 2.2:  This bar graph presents the local p-values we computed at all steps with 
hierarchical structure. 
 
Example 2 (lung cancer data).  This dataset contains expression levels for 835 
unique genes represented by 918 cDNA clones in tissues harvested from lung cancer 
patients and normal individuals (Garber et al. 2001).  Specifically, expression levels are 
measured in 41 adenocarcinomas (ACs), 16 squamous cell carcinomas (SCCs), five large 
cell lung cancers (LCLCs), five small cell lung cancers (SCLCs), five normal lung 
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samples, and one normal fetal lung sample.  Based on the Complete Linkage method and 
Pearson’s correlation coefficient as a measure of similarity in the CLUSTER software, 
hierarchical cluster analysis was performed to group the samples according to the degree 
of similarity present in the gene expression data.  In the resulting dendrogram, the AC 
samples appeared in three distinct clusters.  The aim of the study was to examine whether 
the groups of AC samples created by the hierarchical clustering procedure correlated with 
clinical outcomes of the AC patients, that is, whether the Kaplan-Meier survival curves 
differed for these groups (Garber et al. 2001). 
Again, using the same clustering methodology as in the publication (Garber et al. 
2001), we apply this technique to their AC data  and work with the resulting hierarchical 
structure for assessing the local and global p-values.  The dendrogram in Figure 2.3 
details the hierarchical clustering of the data (for the 24 AC samples from patients with 
reported survival information) for steps zero through 22.  For each step in the hierarchy 
we calculate a log-rank statistic and the corresponding local p-value (m = 100,000 
permutation samples).  Figure 2.4 graphically presents these local p-values.  We exclude 
the first two clustering steps (0 and 1) from the figure and further assessments because 
insufficient variability in the log-rank statistic at these steps does not permit meaningful 
calculation of local p-values.  (At the zeroth step of clustering, each patient from the 
survival analysis is in his/her own group.)  At step 22, we observe the minimum local 
p-value of 0.0002, and we calculate the global p-value for this dataset to be 0.0027.  
Thus, the experiment shows a statistically significant result, and clustering was effective.  
It reduced the initial p-value of 0.0306 at step 2 to the global significance level of 
pmin = 0.0027. 
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Figure 2.3  Dendrogram created by clustering data from Garber et al. (Garber et al. 2001) 
 
Legend for Figure 2.3:  This schematized dendrogram reflects the process of clustering 
microarray samples according to the similarity of their gene expression profiles as measured by 
the Pearson correlation coefficient.  Distances between array sample clusters are approximated 
(not to scale) by the vertical axis.  Along the bottom of the dendrogram are the microarray tissue 
samples from individuals for which survival data was available (Garber et al. 2001).  
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Figure 2.4  Results from log-rank tests applied to steps of the hierarchical structure 

















































































Legend for Figure 2.4:  This bar graph displays the local p-values we computed at each step 
within the structure created by hierarchical clustering. 
 
Example 3 (lymphoma data).  The third dataset contains expression levels of 
cDNA clones from genes expressed in germinal center B-cells for 47 samples of diffuse 
large B-cell lymphoma (DLBCL) (Alizadeh et al. 2000).  Hierarchical clustering was 
performed with the CLUSTER program and the Pearson correlation coefficient as its 
similarity measure to group the samples by similarity of gene expression levels for all 
genes expressed in germinal center B-cells.  The resulting dendrogram shows two main 
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branches, one containing samples with expression patterns similar to those of germinal 
center B-cells and one containing samples with expression patterns similar to those of 
activated B-cells.  To examine the clinical relevance of this subdivision of DLBCL, a 
Kaplan-Meier survival analysis for the two groups of patients was performed based on 
the dendrogram’s penultimate clustering step (Alizadeh et al. 2000). 
As with the other datasets, we cluster the data with the same method as published 
(Alizadeh et al. 2000) and use the resulting hierarchical structure for calculations of log-
rank statistics and associated local p-values (m = 100,000 permutation samples) at 
different steps in the hierarchy.  The dendrogram in Figure 2.5 provides the order of 
clustering (for the 40 DLBCL samples from patients with reported survival information) 
for steps zero through 39 while Figure 2.6 graphically presents local p-values at the 
different clustering steps.  As in Example 2, we observe a very small variance in the log-
rank statistic at the first two clustering steps and, therefore, exclude these steps from 
further analysis.  At step 6, we observe the minimum local p-value of 0.0011, with an 
associated global p-value of pmin = 0.0167.  This result is statistically significant at the 5% 
level, and clustering has contributed to an increase in significance because un-clustered 
or only minimally clustered data show much lower significance (higher p-value). 
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Figure 2.5  Dendrogram created by clustering data from Alizadeh et al. (Alizadeh et al. 
2000) 
 
Legend for Figure 2.5:  This schematized dendrogram reflects the process of clustering 
microarray samples according to the similarity of their gene expression profiles as measured by 
the Pearson correlation coefficient.  Distances between array sample clusters are approximated 
(not to scale) by the vertical axis.  Along the bottom of the dendrogram are the microarray tissue 
samples from individuals for which survival data was available (Alizadeh et al. 2000). 
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Figure 2.6  Results from log-rank tests applied to steps of the hierarchical structure 






























































































































Legend for Figure 2.6:  This bar graph displays the local p-values we computed at each step 
within the structure created by hierarchical clustering. 
 
Validation of the algorithm.  We found agreement between our original 
algorithm for determining pmin and the global p-value determined with the analytical 
approach (see section 2.2).  Applying the analytical approach for the two-step dataset (see 
Table 2.2) resulted in a global p-value of 0.026 while our original algorithm computed 
pmin to be 0.023.  The 95% confidence interval for this estimate is [0.020, 0.026].  For the 
nine-step dataset (see Table 2.3), the analytical approach produced lower and upper 
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bounds for pmin of 0.248 and 0.657, respectively.  Our original algorithm computed pmin to 
be 0.371.  A set of naïve bounds can also be created.  By assuming perfect pair-wise 
correlation between tests, one finds the lower bound to be the minimum p-value, which 
for the nine-step dataset was 0.149.  In contrast, by assuming the tests at each step to be 
independent of one another, one finds the upper bound to be the Bonferroni corrected p-
value, which for the nine-step dataset was 1.0.  Thus, the bounds established by using the 
multivariate normal distribution were a substantial improvement over the naïve bounds. 
 
2.4 Discussion 
In hierarchical clustering, evaluating the minimum local p-value in isolation, 
outside of the context of the larger hierarchical structure used to create the data, can 
drastically affect the interpretation of test results.  For example, even though the 
haplotype data show an apparently significant result with a minimum p-value of 0.0292, 
our analysis demonstrates that clustering the same data, but without association between 
haplotypes and disease, has a high chance of obtaining such a “significant” result.  In 
fact, that chance is pmin = 0.1328, which represents the actual significance level of the 
experiment.  On the other hand, as examples 2 and 3 show, clustering can improve the 
significance of a result and provide a result that is statistically significant. 
How can we explain that in some cases clustering is beneficial while in other 
cases it is not?  Presumably, some datasets possess an underlying heterogeneity; that is, 
such datasets are composed of samples from multiple distinct populations.  If the 
information used for clustering (haplotypes for example 1 and gene expression patterns 
for examples 2 and 3) is related to the information used to perform the statistical test (in 
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our examples, proportions of cases to controls and survival times), hierarchical clustering 
will detect the heterogeneity.  Otherwise, the clustering process is random and any 
heterogeneity detected is artificial.  Our approach allows one to distinguish between these 
two situations.  If the clustering process is random because the information used for 
clustering and test statistic are unrelated (or because the dataset is homogeneous), a large 
pmin will result indicating that any small local p-values probably occurred only by chance.  
In contrast, if the clustering process is directed by a measurement strongly related to the 
test statistic, a small pmin will result indicating that any heterogeneity found within the 
hierarchy is most likely real. 
Often when hierarchical clustering is applied to a dataset, it is of interest to 
determine the true number of classes present.  This situation commonly arises in the 
analysis of microarray data.  For instance, as in examples 2 and 3, in the study of human 
cancers, researchers often utilize microarray expression data to cluster samples.  From the 
hierarchical structure created by clustering, it may be of interest to distinguish the 
optimum number of tumor subclasses that are most clinically relevant.  Several statistics-
based methods have been utilized to estimate the true number of groups from such 
microarray expression datasets (Horimoto and Toh 2001; Dudoit and Fridlyand 2002).  
However, such methods rely solely on the expression data itself.  Alternatively, it may 
prove practical in such microarray expression studies to consider additional information 
available, such as survival data, for each sample to distinguish clinically relevant 
subclasses.  Employing our procedure of calculating the local p-values for a test statistic 
at multiple steps within the hierarchy and then selecting the step where the minimum of 
these p-values occurs as the basis for determining the true number of classes which exist 
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for a given dataset may provide an advantage over existing methods.  Of course, if such a 
method for determining the true number of classes is applied, the global p-value will 
provide an assessment of its significance.  However, applying our procedure to some 
datasets, such as the data in Example 3, results in determining a large number of true 
classes.  In fact, the number of classes determined may be so large that the use of these 
expression-based tumor subclasses in clinical diagnosis may not provide a benefit.  
Therefore, in order to increase the practicality of our method, it may prove necessary to 
eliminate some of the lower steps in the hierarchy from eligibility for selecting the 
minimum local p-value and the calculation of its significance. 
Besides determining subclasses for biological samples, hierarchical clustering is 
often employed in the context of microarray expression studies in order to identify groups 
of genes that are regulated in a similar manner.  In these cases, clustering is performed on 
the genes rather than on the samples.  Our method relies on two sets of data – one for 
clustering and a second for the statistical test.  Since the samples possess both expression 
data across genes and survival data, our method is applicable to hierarchies created by 
clustering on samples.  However, genes only possess expression data across samples, and, 
consequently, our method is inappropriate for analyzing the significance of hierarchies 
created by clustering on genes.  
Our approach may be viewed as a contribution to the problem of multiple testing.  
We address this problem by defining a single experiment-wise statistic whose associated 
empirical significance level represents the overall significance of the experiment.  For the 
cases we have examined, the experiment refers to performing a test at each step in a 
hierarchy created by clustering.  However, the meaning of experiment can be expanded to 
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reflect other practices adopted by researchers.  For example, researchers may apply 
several clustering algorithms involving various combinations of clustering methods and 
distance measures before finalizing their choice of clustering algorithm.  Since this 
practice introduces an additional test at each step within each of the trial hierarchies, it 
compounds the effect of multiple testing.  Additionally, in some situations researchers 
may be interested in testing for heterogeneity among groups with multiple measurements.  
For instance, when searching for clinically relevant subclasses of cancer, researchers may 
examine groups for differences in survival times as well as differences in physical 
characteristics of the tumor cells.  Both sets of information may be clinically relevant; 
however, to correct for the additional testing, the meaning of the experiment in 
calculating pmin must be expanded to reflect the entire process employed by the 
researcher.  Of course, it is possible that the process of hierarchical clustering forms 
medically relevant groups that do not display heterogeneity for any of the measurements 
collected.  In this case, our strategy will not find these groups as the true grouping 
structure for the samples. 
Several other methods addressing multiple comparison problems have been 
proposed and are in current use.  In particular, as an alternative to the classical 
significance level, p, the false discovery rate (FDR) has become rather popular (Reiner et 
al. 2003).  However, it is important to keep in mind that p and FDR are not really 
comparable.  The classical significance level, p, is the conditional probability of a 
significant test result given the null hypothesis is true (the expected proportion of false 
positive results among all “false” results, i.e., results obtained under the null hypothesis) 
while FDR is the conditional probability of the null hypothesis being true given a 
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significant test result (the expected proportion of false positive results among all 
“positive” results, i.e., significant test results).  Future research will have to determine 
which of these various approaches to eliminate the effects of multiple testing is most 
effective. 
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CHAPTER 3:  ARE MOLECULAR HAPLOTYPES WORTH IT?  A 
COST EFFECTIVE METHOD FOR TREATING 
MISCLASSIFICATION IN HAPLOTYPE-BASED ASSOCIATION 
 
3.1 Introduction 
While clustering haplotype data may create a situation that requires correction for 
the multiplicity of testing, other haplotype-based association studies in which no 
clustering is employed face complications as well.  One such complication is the issue of 
haplotype misclassification. 
Although recent advances in molecular biology have produced techniques to 
unequivocally ascertain phased haplotypes (Michalatos-Beloin et al. 1996; Clark et al. 
1998; Yan et al. 2000; Douglas et al. 2001; Patil et al. 2001; Burgtorf et al. 2003; Ding 
and Cantor 2003; Horan et al. 2003; Hoppe et al. 2004; Proudnikov et al. 2004; Hoppe et 
al. 2006), such molecular haplotyping techniques are seldom employed due to their 
expense and incongruity to automation.  A more pragmatic alternative is to estimate 
haplotype frequencies or infer haplotype pairs by applying statistical methods to 
multilocus genotypes (Clark 1990; Xie and Ott 1993; Terwilliger and Ott 1994; Excoffier 
and Slatkin 1995; Hawley and Kidd 1995; Long et al. 1995; Zhao et al. 2000; Stephens et 
al. 2001b; Zhao and Sham 2002; Stephens and Donnelly 2003).  Although knowledge of 
parental genotypes can simplify the problem, for haplotype-based association studies the 
sample design generally calls for collecting DNA on unrelated individuals, and, in this 
case, the statistical methods for haplotype estimation must consider each individual as an 
independent observation.   
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For these non-familial study designs, several methods are available to estimate 
haplotype frequencies and/or infer haplotype pairs.  The main methods follow one of two 
approaches—1) relying on the EM algorithm (Dempster et al. 1977) for a likelihood 
approach (Xie and Ott 1993; Excoffier and Slatkin 1995; Hawley and Kidd 1995; Long et 
al. 1995) and 2) using a Bayesian approach to apply a prior based on coalescence theory 
(Stephens et al. 2001b; Stephens and Donnelly 2003) or a Dirichlet prior (Niu et al. 
2002).   The EM algorithm-based methods are implemented in SNPHAP (see Electronic 
Resource Information), HAPLO (Hawley and Kidd 1995), and PL-EM (Qin et al. 2002) 
while the Bayesian approaches are implemented in PHASE (Stephens et al. 2001b) (see 
Electronic Resource Information) and HAPLOTYPER (Niu et al. 2002).  Several 
investigators have examined the accuracy of these approaches for both haplotype 
frequency estimation and haplotype inference (Fallin and Schork 2000; Tishkoff et al. 
2000; Clark et al. 2001; Xu et al. 2002; Stephens and Donnelly 2003; Adkins 2004; Kang 
et al. 2004; Niu 2004; Xu et al. 2004; Heid et al. 2005; Sabbagh and Darlu 2005; Zhang 
et al. 2005; Marchini et al. 2006; Proudnikov et al. 2006). 
Many statistical methods are available to perform tests of haplotype-based case-
control association.  One method calculates the likelihood of the data in terms of the 
estimated haplotype frequencies.  An alternative method relies on the use of a 
contingency table containing the case-control counts for each inferred haplotype.  Since it 
applies the same format as the classic genotypic and allele case-control studies and 
accounts for each phased haplotype explicitly, many researchers prefer the latter 
approach.  One can determine the counts in the contingency table by inferring phased 
haplotypes for each individual (or by multiplying each haplotype frequency estimate by 
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the total number of haplotypes in the study).  Once the contingency table contains the 
haplotype (or diplotype) counts, a Pearson χ2 test or a likelihood ratio test can be 
performed.  However, the counts entered in the contingency table may misrepresent the 
true situation since inferred haplotypes (and haplotype estimates) are prone to errors.  
These haplotype misclassification errors may affect the behavior of the statistical test 
performed. 
Thus, the purpose of this work is to address the effects of haplotype 
misclassification on the false positive rate and power of commonly used tests of 
haplotype-based association.  Specifically, this research aims to 1) classify the nature of 
the misclassification present in calling phased haplotypes; 2) determine the 
appropriateness of using the asymptotic χ2 distribution and permutation methods to 
evaluate the significance of the test statistics we employ; and 3) compare the power of 
our test statistic which accounts for haplotype misclassification with the power of the 
standard likelihood ratio test statistic when the costs are fixed. 
 
3.2 Methods 
Test statistics.  In order to detect an association between a haplotype pair and 
disease status, we employed two statistical tests on 2 × k contingency tables where k is 
the number of haplotype pair categories found by inference.  These tests include the 
standard likelihood ratio test (LRTstd) and a likelihood ratio test that employs a double-
sampling approach to allow for the misclassification inherent in the haplotype inference 
procedure (LRTae).  The LRTstd is a likelihood ratio statistic that treats the called 
haplotype pairs as observations, and as a result the likelihood is the multinomial 
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distribution where the called haplotype pairs are the categories (Agresti 1996).    The 
LRTae statistic is a likelihood ratio statistic that employs a double-sampling procedure to 
account for the misclassification present in a haplotype inference.  On all the individuals 
in the study, there is a fallible measure (Tenenbein 1970; Tenenbein 1972), the haplotype 
pairs inferred from the multilocus genotypes, and on a subset of these individuals, there is 
a second measure which is considered to be infallible (Tenenbein 1970; Tenenbein 1972), 
molecular haplotypes.  By comparing the fallible data with infallible data, the LRTae 
procedure estimates the misclassification rates present in the fallible data and 
incorporates this information into the likelihood calculation (Gordon et al. 2004). 
 
Computation of the LRTstd and LRTae statistics.  For completeness, details 
regarding the LRTstd and LRTae statistics including notation and computation as 
described by Gordon et al. are provided in this section.  We present the mathematical 
basis for computation of the LRTstd and LRTae statistics.  This work largely follows from 
the original publication on the LRTae statistic (Gordon et al. 2004).  The primary 
difference is that, in this work, we assume only misclassification in haplotype pairs 
(called “genotypes” in the original publication) and assume no misclassification of 
phenotype.  Because we do not collect a second phenotype measurement, we assume that 
all phenotype classifications are correct.  We begin with some notation. 
Notation.  For all terms, the index  is either 0 (case) or 1 (control) and the 





We use prime superscripts to distinguish true categories from observed categories.  
For example, refers to the true haplotype pair classification for an individual.  Also, we 
use the superscript t to denote “true” (as compared with observed) when referring to 
either an event or a parameter.  For example, the notation represents the event that an 
individual’s true haplotype pair classification is , whereas the notation represents 





j  (see below).  
Similarly, the notation represents the true probability of the haplotype pair  for 
individuals with (true) phenotype classification i , whereas the notation represents 




j  for individuals with (true) phenotype 
classification .  With this notation, we may distinguish between the events and 
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jji nnn  ; Note that n is the total sample size. 
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t
iY ' =Event that an individual has phenotype )1,0'(,' =ii . 
jX =Event that an individual has observed haplotype pair kjj ≤≤1, . 
t
jX ' =Event that an individual has true haplotype pair kjj ≤≤ '1,' . 
t
jiX '' =Event that an individual has phenotype )1,0'(,' =ii and true haplotype pair 
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 )|Pr( '' jjjj XX=θ  
Note: When , these parameters are referred to as misclassification parameters 
(Tenenbein 1972; Gordon et al. 2002). We make use of the double-sample data structure 
to determine estimates of haplotype pair misclassification values 
jj ≠'
jj 'θ .  The 
misclassification parameter estimates are (see below).  jj 'θ̂ += ''' /ˆ jjjjj mmθ
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)',1( ' kjjm jj ≤≤ = The number of individuals that have been classified by the fallible 
method as haplotype pair j and by the infallible method as haplotype pair . 'j
 '' ∑=+
j
jjj mm . 
)ln( ,1 stdL
jp0
= Log-likelihood of data when not correcting for misclassification, where 
haplotype pair frequencies are allowed to differ among different phenotype classes 
(i.e., is not necessarily equal to  for every 
jip '
jp1 j ) (also see equation 3.1b below). 
)ln( ,0 stdL = Log-likelihood of data when not correcting for misclassification, where 
haplotype pair frequencies are constrained to be equal among different phenotype 
classes (i.e., for every 
jip '
jjj ppp *10 == j ) (also see equation 3.1b). 
)ln( ,1 aeL = Log-likelihood of data as represented in equation (3.4), where haplotype pair 
frequencies ' are allowed to differ among different phenotype classes.  (i.e., is not 









j pp 1'0 =
= Log-likelihood of data as represented in equation (3.4) below, where haplotype 
pair frequencies are constrained to be equal among different phenotype classes.  (i.e., 




jj p '*' = 'j
 
Log-likelihood of observed data and likelihood ratio test statistics 
We compute the log-likelihood of the observed data under the null and alternative 




j pppH '*'1'00 : ==
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haplotype pairs .  The alternative hypothesis is for at least one ' .  
Under either hypothesis, we have, by definition, the log-likelihood of the data given by: 
'j t j
t






















ijjiae XXXYnL   (3.1a)       
where the notation is the probability of observing event A and event B and 
event C and so forth and represent the counts for different categories of double-
sample information (see above for definitions of all notation).  For example,  is the 
number of individuals who have been double-sampled for haplotype pair classification 
and who have true phenotype classification i , true haplotype pair classification , and 














) and the subscripts ' run over all haplotype pair 
classifications (1 ).   
When a double-sample has not been collected or when we assume that there is no 



































     (3.1b) 
A key assumption in our work is that the observed haplotype pair is only dependent on 
the underlying true haplotype pair and not on phenotype so that 
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jijjjjiae qpnqpnL θθ   (3.4) 
From equation (3.4) we can determine the log-likelihood of the data under  using the 
EM algorithm estimates of and  (see (Gordon et al. 2004)). Similarly, we can 
determine the log-likelihood of the data under  using the EM algorithm estimates of 













It follows from equation (3.4) that the log-likelihoods ln( and  
(equation (3.1a)) are completely determined by misclassification parameters 
),0 aeL )ln( ,1 aeL
jj 'θ , the true 
parameters , and sample counts ( ).  In the previous sentence, 
 refers to the situation under the null hypothesis, where the terms  in equation 
(3.4) are replaced by .  In contrast,  refers to situation under the alternative 
hypothesis, where the terms  in equation (3.4) remain.  Our test of versus is a 
likelihood ratio test (Kendall et al. 1994), which we call the likelihood ratio test allowing 


















j ' )ln( ,1 aeL
t
jip '' 0H
ae.  It is given by   
LRTae )],ln()[ln(2 ,0,1 aeae LL −=          (3.5a) 
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where and are determined using equation (3.4) with the EM algorithm 
estimates of the various parameters.  Asymptotically, LRT
)ln( ,1 aeL )ln( ,0 aeL
ae is distributed as , where 
the degrees of freedom (df) are k – 1 for a set of k observed haplotype pairs (Gordon et al. 
2004). For small samples or in situations where the asymptotic distribution may not hold, 
we can compute p-values via permutation (Gordon et al. 2004; Proudnikov et al. 2006).   
2
1−kχ
The standard likelihood ratio test, denoted LRTstd, that does not make any 
correction, has its log-likelihoods computed solely from the observed data.  That is,  
LRTstd )],ln()[ln(2 ,0,1 stdstd LL −=         (3.5b) 
where the log-likelihoods under the null and alternative hypotheses are computed using 
the estimates , ( ) that are then 
substituted into equation (3.1b) (Rice and Holmans 2003).  When there is no correction 
for misclassification, there is no need to compute under both the null and alternative 
hypothesis, as the terms with will cancel in the expression for the difference of the log-






















Permuted and asymptotic p-values.  We applied two methods for evaluating the 
p-value or statistical significance of each statistic.  The first method relies on using the 
central χ2 distribution to find the p-value since, according to statistical theory under the 
null hypothesis of no association, twice the natural logarithm of the likelihood ratio 
follows the central χ2 distribution asymptotically for large sample sizes (Agresti 1996).   
In addition, it has been shown that when Cochran’s rule is followed (more than five 
observations in each cell of the contingency table), the presence of non-differential 
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misclassification does not affect the distribution of the likelihood ratio test statistic under 
the null hypothesis of no association (Mote and Anderson 1965; Gordon et al. 2004).  
The second method employs permutation testing to generate the distribution of the test 
statistic under the null hypothesis and to determine its statistical significance.  In this 
thesis, p-values found with the former and latter approaches are referred to as asymptotic 
p-values and permutation p-values, respectively. 
 
Description of data generation and analysis.  To investigate the behavior of 
these test statistics for a variety of situations, we applied these statistical tests to many 
simulated datasets.  Figure 3.1 illustrates the procedure we used to simulate the data and 
to evaluate the false positive rate and power at fixed significance levels for each statistic.  
For the analysis of each replicate dataset simulated, the multilocus genotype data from 
cases and controls were pooled to infer haplotype pairs for each individual.  Individuals 
were assigned the haplotype pair with the highest posterior probability.  The posterior 
probability of a given haplotype pair is defined as the probability of that haplotype pair 
being the true haplotype pair conditioned on the observed multilocus genotypes.  For 
example, consider two SNP marker loci where A and a represent the alleles at the first 
locus while B and b represent the alleles at the second locus.  The posterior probability of 






===    
by applying Bayes’ Theorem and simplifying.  The EM algorithm can be used to estimate 
the probability of each haplotype in the posterior probability expression from multilocus 
genotypes. 
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The inferred haplotypes are sufficient for the computation of LRTstd; however, 
LRTae requires additional information in the form of molecular haplotypes for a subset of 
the individuals in the study.  We employed two alternative procedures for selecting 
individuals for the double-sample (individuals with molecular haplotypes in addition to 
genotypes).  In one selection scheme, individuals were selected randomly.  In the other 
selection scheme, individuals possessing the most ambiguity in their statistically inferred 
haplotype pairs were prioritized in selecting the double-sample.  Specifically, we double-
sampled those individuals with the smallest posterior probabilities associated with their 
inferred haplotype pair up to a posterior probability threshold, δ, of 0.85 or until the 
number of individuals specified by the maximum double-sample proportion was reached.  
Therefore, under this second selection scheme the number of individuals double-sampled 
varied between replicate datasets.  In this thesis, the former and latter procedures for 




Figure 3.1  Schematic flow chart illustrating the procedure for data simulation and 
analysis 




















Examine the false positive rate for several significance thresholds 




Simulate haplotypes from known population frequencies 
and arbitrarily assign to cases and controls.A)
Simulate haplotypes from known frequencies 
(conditional on affection status).  These conditional 









Legend for Figure 3.1:  This schematic flow chart illustrates the procedure employed for 
computing (A) type I error and (B) power by way of data simulation. 
 
Two SNP scenario 
Evaluation of false positive rate for permutation and asymptotic p-values.  For 
the simplest non-trivial case, the scenario where the haplotype under evaluation includes 
two SNPs, we applied a fractional factorial design (Box et al. 1978) to perform a 
comprehensive study of type I error.  For the type I error, haplotype pairs were inferred 
using both SNPHAP v 1.3.1 (see Electronic Resource Information) and PHASE v 2.1.1 
(Stephens et al. 2001b) (see also Electronic Resource Information).  Table 3.1 contains 
the fractional factorial design settings for the study of type I error for the scenario 
involving two SNP markers.  We consider a )2(2 g1  fractional factorial design, where 
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g = 6.  Because of redundancy, we were able to reduce the number of experimental runs 
from 32 to 18.  For instance, under the null hypothesis of no association, a run with 1000 
cases and 250 controls is equivalent to a run with 250 cases and 1000 controls (with all 
other factors having equal settings to those for the first run).  During each run, 10,000 
replicate datasets were simulated.  We performed the 18 runs with both of the two 
alternative procedures for selecting the double-sample – random and threshold double-
sample selection.  For the threshold double-sample selection method, δ was 0.85, and the 
maximum double-sample proportion was set to the value of α in the fractional factorial 
design. 
 
Table 3.1  Fractional factorial design parameter settings for the study of type I error 
assuming the haplotype under investigation contains two SNP markers 
Description of parameter Low High 
Number of cases 250 1000 
Number of controls 250 1000 
Minor allele frequency at locus 1 0.1 0.5 
Minor allele frequency at locus 2 0.1 0.5 
LD between locus 1 and 2 (measured by D’) 0 0.9 
Proportion of individuals double-sampled (α) 0.25 0.75 
 
Legend for Table 3.1: This table presents the settings for all parameters considered in the type I 
error simulations assuming the haplotype under investigation contains two SNP markers.  We 
consider a )2(2 g1 fractional factorial design, where g = 6.  The number of experimental runs 
was reduced from 32 to 18 due to redundancy.  D’ is the standardized linkage disequilibrium 
measure.  The simulations included 10,000 replicates, and haplotype pairs were inferred using 
both SNPHAP v 1.3.1 and PHASE v 2.1.1.  LRTae was computed with the random and threshold 
double-sample selection methods for all 18 runs in the fractional factorial design.  For the 
threshold double-sample selection method, δ was 0.85, and the maximum double-sample 
proportion was set to the value of α in the fractional factorial design. 
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To evaluate each test statistic’s ability to maintain the correct type I, we examined 
the distribution of the p-values computed for data simulated under the null hypothesis of 
no association.  We performed two goodness-of-fit tests, the Kolmogorov-Smirnov (KS) 
and the Anderson-Darling (AD) tests (DeGroot 1991), to determine whether the p-values 
deviate significantly from the standard uniform distribution and examined the false 
positive rate for significant thresholds of 0.05, 0.01, and 0.001 .  
 
Evaluation of power for fixed cost.  We also evaluated the behavior of these 
statistics under the hypothesis that a disease allele at an unobserved locus exists in 
linkage disequilibrium (LD) with the haplotype under study.  Table 3.2 contains the 
factorial design settings for the power study in the scenario involving two SNP markers.  
The factorial design includes three factors, disease model, genotype relative risk (Schaid 
and Sommer 1993) for the homozygote genotype (R2), and the disease allele frequency 
(DAF).  Each factor contains two levels.  For the disease model factor, the two levels are 
a dominant disease model and a multiplicative disease model.  The dominant disease 




12 RR = 1 and R2 are the genotype relative risks for the heterozygote and 
homozygote genotypes, respectively.  Specifically, the genotype relative risks are defined 
as the following.  If the penetrances, , are defined by if
allele) disease of copies |dPr(affecte if i = , where 2  1,  0,=i , the genotype relative 
risks, R1 and  R2, are defined by  
011 ffR = and 022 ffR = , respectively (Schaid and Sommer 1993). 
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Table 3.2  Factorial design parameter settings for the study of power assuming the 
haplotype under investigation contains two SNP markers 
Description of parameter Low High 
Disease model dominant multiplicative 
Genotype relative risk of homozygote (R2) 2 3.5 
Disease allele frequency (DAF) 0.07 0.27 
 
Legend for Table 3.2: This table presents the settings for all parameters considered in the power 
simulations assuming the haplotype under investigation contains two SNP markers.  We consider 
a  factorial design, where g = 3.  The dominant disease model requires that  while the 
multiplicative disease model requires , where R
g2 12 RR =
2
12 RR = 1 and R2 are the genotype relative risks 
for the heterozygote and homozygote genotypes, respectively.  For the random double-sample 
selection method, the proportion of individuals double-sampled (α) was 0.75 while a haplotype 
pair posterior probability threshold (δ) of 0.85 and a maximum double-sample proportion of 0.75 
were used for the threshold double-sample selection method.  The cost ratio of molecular 
haplotyping to genotyping (r) was 5.  For each combination of settings, 1000 replicate datasets 
comprised of 500 cases and 500 controls were simulated.  The disease prevalence was 0.025; the 
LD between the disease allele and the linked haplotype was 0.9 (measured by D’); and the 
population haplotype frequencies were 0.05, 0.15, 0.25, and 0.5.  The haplotype with a frequency 
of 0.05 was linked to the disease allele when DAF = 0.07, and the haplotype with a frequency 
0.25 was linked to the disease allele when DAF = 0.27.  Haplotype pairs were inferred using both 
SNPHAP v 1.3.1 and PHASE v 2.1.1. 
 
As with the study of type I error, we inferred the haplotypes for the power 
simulations with both SNPHAP v 1.3.1 and PHASE v 2.1.1.  The proportion of 
individuals double-sampled, α, for the LRTae method (random double-sample selection) 
was set at 0.75.  For the threshold double-sample selection, δ was set at 0.85, and the 
maximum double-sample proportion was 0.75.  In the power simulations, the conditional 
(on case status) haplotype frequencies were found from the specified disease model 
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parameters by a method described by Sham and subsequently by De La Vega et al. 
(Sham 1998; De La Vega et al. 2005) (also see the Power for Association with Error 
(PAWE) website at http://linkage.rockefeller.edu/derek/pawe1.html).  However, we 
selected a specific haplotype to be in LD with the disease allele.  For completeness, 
details regarding the conditional haplotype frequencies including notation and 
computation as described by De La Vega et al. (2005) are provided at the end of this 
section.  During each run, 1000 replicate datasets comprised of 500 cases and 500 
controls were simulated.  For these simulations, the disease prevalence was 0.025; the LD 
between the disease allele and the linked haplotype was 0.9 (measured by D’ (Lewontin 
1964)); and the population haplotype frequencies were 0.05, 0.15, 0.25, and 0.55.  
Selection of the specific haplotype in LD with the disease allele depended on the disease 
allele frequency (DAF).  The haplotype occurring with a frequency most similar to that of 
the disease allele was selected.  Thus, haplotypes with frequencies of 0.05 and 0.25 were 
selected as the variant in LD with the disease when the DAF was set at 0.07 and 0.27, 
respectively.  As with the evaluation of the false positive rate, we performed all 8 runs 
from the factorial design using both random and threshold double-sample selection. 
To compare the power of the two test statistics, we evaluated the power of the 
statistics under fixed cost conditions.  Since the LRTae requires the additional cost 
associated with obtaining molecular haplotypes on a subset of the samples, we reduced 
the number of samples when the LRTae statistic was applied so that the same total cost 
would be incurred as for the runs with the LRTstd.  The reduced sample size for the LRTae 



























,      (3.6) 
where NDS is the sample size for the LRTae; N is the sample size for the LRTstd; Cp is the 
cost of phenotyping; Cg is the cost of genotyping; r is the cost ratio of molecular 
haplotyping to genotyping (Cmh/Cg); and α is the proportion of individuals in the LRTae 
sample which have molecular haplotypes determined (double-sampling proportion).  We 
consider the phenotyping costs, Cp, to include costs associated with ascertainment and 
diagnosis.  We illustrate fixed cost sample sizes for the following example.  With settings 
of Cp/Cg = 25, r = 5, α = 0.75, and N = 1000 for the LRTstd method, then the 
corresponding total sample size for the LRTae method, NDS, is 874.  The reader should 
note that the reduced sample size results from the additional cost incurred by double-
sampling 75% of the total sample for the LRTae method.  If Cp/Cg = 1000, note this term 
will dominate the expression in equation (3.6) and the fixed cost sample size, NDS, will 
not differ greatly from the sample size for the LRTstd, N.  All power simulations were 
performed under fixed cost conditions.  Since the double-sample proportion, α, varies 
from replicate to replicate when the threshold double-sample selection method is 
employed, we first performed several test runs to determine the mean double-sample 
proportion, α .  Using α , we computed NDS*, the total sample size for the LRTae 
determined from the expectation of α.  For a specific disease model, we performed a 
comprehensive study of the power difference between the LRTae and LRTstd for the 
situation of a haplotype comprised of two SNPs. 
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Computation for conditional haplotype frequencies.  For completeness, here we 
illustrate how the conditional (on case status) haplotype frequencies were computed as 
described by De La Vega et al. (2005). 
List of notation 
Marker Loci: 
hi = population haplotype frequency of the ith haplotype (out of w possible haplotypes) 
Disease Locus: 
pd = allele frequency of disease-causing allele at the disease locus 
p+ = allele frequency of the wild-type allele at the disease locus 
Disease-Marker Haplotypes: 
h+,j = frequency of disease-marker haplotype containing the wild-type allele (+) at the 
disease locus and the marker haplotype j.  This is the probability that the wild-type allele 
is on the same chromosome as a given haplotype j. 
hd,j = frequency of disease-marker haplotype containing the disease allele (d) at the 
disease locus and the marker haplotype j.  This is the probability that the disease allele is 
on the same chromosome as a given haplotype j. 
Disequilibrium Parameters: 
D’ = standardized LD parameter (Lewontin 1964), ( 0 1≤≤ 'D ) 
Dmax = , where z is the haplotype selected to be LD with the disease 
allele 
[ zzd hp),h(pmin +−1 ]
Penetrances: 
f0 = Pr{affected|++ at disease locus} 
f1 = Pr{affected|+d at disease locus} 
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= Pr{individual possesses marker haplotypes j1 and j2|affection status i}, 
, i = 0 (affected) or 1 (unaffected) wj ≤2
3, ji
I = Pr{individual possesses marker haplotype j3|affection status i}, , i = 0 
(affected) or 1 (unaffected) 
wj ≤≤ 31
Prevalence: 
φ  = disease prevalence =  2
2
10
2  )1(2 )1( fpfppfp dddd +−+−
LD Pattern and Disease-Marker Haplotype Frequencies: 
Because the number of linkage disequilibrium parameters increases as the number 
of haplotypes increases (Lewontin 1964), we simplify the analysis by constructing an LD 
pattern that, for estimated haplotype frequencies , is a function of a single 
parameter D’.  Note that D’ can vary between 0 and 1, where 0 represents linkage 
equilibrium and 1 represents complete linkage disequilibrium.  We now describe the LD 
pattern for a “selected” haplotype, z, where 
whh ,,1 K
wz ≤≤1 .  By “selected”, we mean that 
haplotype z is in positive LD with the disease allele (occurs in phase with the disease 





















)LD(    (3.7) 
Using the LD pattern described above, for the “selected” haplotype z, we write the 








−= ++      (3.8) 
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Since h+,j and hd,j are the probabilities that the jth marker haplotype resides on the same 
chromosome as the wild-type and disease allele, respectively,  for j = z (the 
haplotype “selected” to be LD with the disease allele). 
j,j,d hh +≥
Applying the definition of conditional probability and the law of total probability, we can 
write the conditional haplotype pair frequencies as 
( )[ ]






































50 .    (3.10) 
We used these conditional (on case status) haplotype frequencies as the generating 
frequencies in our simulations under the alternative hypothesis (power runs).  Using the 
above equations, we were able to compute these conditional haplotype frequencies from 
the disease prevalence (f), the disease allele frequency (pd or DAF), the disease model, 
the genotype relative risk for the homozygote (R2), the population haplotype frequencies 
(hj), the “selected” haplotype (z), and the LD between the “selected” haplotype, and the 
disease allele (measured by D’).  For example, suppose we set f = 0.025, pd = 0.07, 
R2 = 3.5, h1 = 0.05, h2 = 0.25, h3 = 0.15, h4 = 0.55, z = haplotype 1, and D’ (between d 
and the haplotype 1) = 0.9 and use a dominant disease model.  Since the dominant disease 
model requires that , the genotype relative risk for the heterozygote (R12 RR = 1) must 
also be 3.5.  Using the definitions for the genotype relative risks ( 011 ffR = and 
022 ffR = ) and the definition of the disease prevalence, we find that f0 = 0.019, 
f1 = 0.065, and f2 = 0.065.  Then by using the definition of Dmax as well as equations (3.7) 
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and (3.8), we find each disease-marker haplotype frequency (h+,j and hd,j).  Now with the 
penetrances (f0,  f1, and f2) and the disease-marker haplotype frequencies (h+,j and hd,j), 
we can use equation 3.9 to find the conditional haplotype pair frequencies ( ).  




,.I 123001 = ,.I 048011 = ,.I 231002 =  ,.I 250012 = ,.I 139003 =  ,.I 150013 = ,508.I 004 = and 
.  Note that the frequency of the “selected” haplotype (haplotype 1) is elevated 
in cases (relative to the population frequency for this haplotype) while the frequency of 





Evaluation of false positive rate and power for fixed costs.  Through additional 
simulations, we investigated the behavior of these statistics when applied to haplotypes 
comprised of larger numbers of SNPs.  Because these simulations required additional 
computational time, we only utilized SNPHAP v 1.3.1 (see Electronic Resource 
Information) for inferring haplotypes.  Our simulations were based on haplotype 
frequencies from two datasets – 1) a dataset of molecular haplotypes with very high 
levels of pair-wise LD between markers (Horan et al. 2003) and 2) a dataset of multilocus 
genotypes from the TAP2 gene within the major histocompatibility complex, a region 
with low pair-wise LD between markers (International HapMap Consortium 2003; 
International HapMap Consortium 2005) (see also Electronic Resource Information), 
hereafter referred to as the Horan and HapMap TAP2 datasets, respectively.  Figure 3.2 
displays the inter-marker LD for each of these two datasets using GOLD plots (Abecasis 
 72
and Cookson 2000).   For the Horan dataset, we determined the generating population 
haplotype frequencies for our simulations directly using the counting method (Ott 1999).  
For the HapMap TAP2 dataset, we found the generating population haplotype 
frequencies for our simulations indirectly using SNPHAP v 1.3.1 (see Electronic 
Resource Information).  In the latter case, haplotype frequencies were estimated from the 
parents of each trio in the Yoruba population group from the International HapMap 
Project.  For the type I error simulation studies, 1000 replicate datasets containing 250 
cases and 250 controls were simulated.  For the type I error runs based on the Horan data 
and the HapMap TAP2 data, we simulated haplotypes comprised of 15 SNPs and 10 
SNPs, respectively, while for the power runs, we simulated haplotypes comprised of 5 
SNPs (Horan et al. 2003; International HapMap Consortium 2003; International HapMap 
Consortium 2005).  Figure 3.2 specifies the SNPs we utilized from each dataset in the 
type I error and power runs.  For the Horan dataset, we provide the SNP markers’ 
positions (relative to the transcription start site of the GH1 gene) while for the HapMap 
TAP2 dataset, we provide the name of the SNP marker.  As a result, we simulated 
haplotypes using 17 haplotype variants with frequencies greater than 0.01 for both the 
Horan and HapMap TAP2 type I error simulations.  In addition, we simulated haplotypes 
using 5 and 10 haplotype variants with frequencies greater than )t( 21 , where t is the 
total number of individuals (t = 153 for the Horan dataset and t = 60 for the HapMap 
TAP2 dataset), for the Horan and HapMap TAP2 power simulations, respectively.  For 
each scenario, we normalized the frequencies so that they summed to unity.  As with the 
power studies for the two SNP scenario, the selection of the specific haplotype in LD 
with the disease allele depended on the DAF.  The rationale for the selection procedure is 
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provided in section 3.3 addressing multi-SNP power.  For multi-marker type I error and 
power studies, we employed both the random and threshold double-sample selection 
methods in computing the LRTae statistic.  When the random double-sample selection 
method was utilized, the double-sample proportion, α, was 0.75.  When the threshold 
double-sample method was utilized, the setting of δ = 0.85 was used, and the maximum 
proportion of individuals included in the double-sample was 0.75. 
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Figure 3.2  GOLD plots for the Horan and HAPMAP TAP2 datasets 
 
 
Legend for Figure 3.2: These GOLD plots (Abecasis and Cookson 2000) show the pair-wise intermarker LD in terms of D’ for (A) 15 SNP 
markers within the proximal promoter region of human pituitary expressed growth hormone (GH1) and (B) 10 SNP markers with the TAP2 gene.  
In (A), the SNP markers are listed as their position relative to the transcription start site of the GH1 gene whereas in (B), the SNP markers are 
listed by their National Center for Biotechnology Information (NCBI) reference SNP (rs) numbers.  Physical distances are provided.  All SNP 
markers displayed were included in the type I error study while SNP markers accompanied by an asterisk (*) were included in the power study.
Identifying the nature of haplotype pair misclassification.  For all the 
simulations performed, we recorded the details of the misclassifications that occurred.  
Specifically, for every replicate we computed the misclassification rates, 
j'jθ  = Pr{observed haplotype pair classification is j| true haplotype classification is j’}, 
where  (Gordon et al. 2004).  Previous research studying genotype misclassification 
rates in tests of genotypic association provides the motivation for ascertaining these 
values (Kang et al. 2004).  This notation is also used in the description of the LRT
jj ≠'
std and 
LRTae statistics.  
 
3.3 Results 
Two SNP scenario.  Our type I error and power results from the simulations 
utilizing SNPHAP v 1.3.1 and PHASE v 2.1.1 for the haplotype inference were almost 
identical.  Although we present graphs and tables that display the results where SNPHAP 
v 1.3.1 provided the haplotype inference, the reader should note that similar results were 
found using  PHASE v 2.1.1 for the haplotype inference. 
 
Evaluation of false positive rates for permutation and asymptotic p-values.  The 
type I error simulations demonstrated that the approach for determining statistical 
significance is critical for maintaining the correct false positive rate.  While KS and AD 
test results indicated that the distribution of permutation p-values was consistent with the 
standard uniform distribution, they indicated that the distribution of asymptotic p-values 
did not resemble the standard uniform distribution.  These results were reinforced by the 
false positive rates we found.  For all the simulation runs displayed in Table 3.1, 
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Figure 3.3 shows the false positive rate for various significance thresholds for  LRTstd and 
LRTae (using the random and threshold double-sample selection methods) association 
tests in which statistical significance was indicated by permutation and asymptotic p-
values.  The graph in Figure 3.3A shows that asymptotic p-values for  LRTae are anti-
conservative while those for LRTstd fluctuate between conservative and anti-conservative 
values when a significance threshold of 0.05 is applied.  In contrast, the permutation p-
values for both statistics consistently maintain the nominal significance level of 0.05.  We 
found that the asymptotic and permuted p-values demonstrated similar behavior for 
significance thresholds of 0.01 and 0.001.  However, for the 0.001 significance threshold, 
the p-values appear more scattered due to the scale at this extreme significance threshold.   
Haplotype pairs were inferred using SNPHAP v 1.3.1 for the simulation results displayed 
in the graph.  These results are not surprising since several simulation parameter settings 




Figure 3.3  Line graph illustrating estimates of the false positive rate at various 
significance levels for LRTstd and LRTae 
 
Legend for Figure 3.3: The line graphs show estimates of the false positive rate at the (A) 0.05 
significance level, (B) 0.01 significance level, and (C) 0.001 significance level for LRTstd and 
LRTae with p-values determined by both permutation and the asymptotic central χ2 distribution.  
The 18 runs correspond to the combinations of parameter settings described in Table 3.1.  For all 
18 runs, LRTae was computed with the random and threshold double-sample selection methods.  
When the threshold double-sample method was utilized to compute LRTae, the setting of δ = 0.85 
was used, and the maximum proportion of individuals included in the double-sample was the 
value for α specified by the fractional factorial design.  Haplotype pairs were inferred using 
SNPHAP v 1.3.1 for the simulation results displayed in the graph. 
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Evaluation of power for fixed cost.  Based on the results for the false positive 
rates, we conclude that power can only be evaluated using the permutation p-values.  We 
compare the power of LRTae (using the random and threshold double-sample selection 
methods) to LRTstd.  Table 3.3 presents summary statistics for the power difference 
(LRTae power – LRTstd power) at various significance levels for the two cost ratios 
 and  using the 8 parameter settings from the factorial design 
(Table 3.2).  Note that in all runs, we set the cost ratio of molecular haplotyping to 
genotyping, r, to be 5, and the proportion of individuals to be double-sampled, α, to be 
0.75 (for the random double-sample selection method).  The values reported correspond 
to the simulations utilizing SNPHAP v 1.3.1.   
25/ =gp CC 1000/ =gp CC
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Table 3.3  Summary statistics for power difference (LRTae – LRTstd) at various significance levels 






25/ =gp CC 1000/ =gp CC 25/ =gp CC 1000/ =gp CC 25/ =gp CC  1000/ =gp CC  
minimum       -0.061 -0.004 -0.062 0.001 -0.056 0.000
median       0.004 0.014 0.005 0.019 -0.007 0.021random 
maximum       0.036 0.105 0.033 0.089 0.025 0.135
minimum       -0.010 -0.004 0.001 0.003 -0.001 0.000
median       0.043 0.045 0.048 0.048 0.064 0.068threshold 
maximum       0.126 0.162 0.117 0.123 0.151 0.152
 
Legend for Table 3.3: This table presents summary statistics for the power difference between the LRTae and LRTstd methods (p-values evaluated 
using permutation) at the 0.05, 0.01, and 0.001 significance levels.  Results are shown for LRTae computed using both the random and threshold 
double-sample selection methods.  The methods are compared for fixed costs where the power for LRTae is computed under two conditions, 1) the 
cost ratio of phenotyping to genotyping (Cp/Cg) is 25 and 2) the cost ratio of phenotyping to genotyping (Cp/Cg) is 1000.  The sample size for 
LRTstd, N, is 1000 (500 cases, 500 controls).  For the LRTae statistic, settings of α = 0.75 (random double-sample selection method) and r = 5 were 
used.  When the threshold double-sample selection method was utilized to compute LRTae, the setting of δ = 0.85 was used, and the maximum  
proportion of individuals included in the double-sample was 0.75.  Haplotype pairs were inferred using SNPHAP v 1.3.1.
For the random double-sample selection method, the minimum power difference 
occurred when C  for a dominant disease model with R25/ =gp C 2 = 2 and DAF = 0.27 at 
a significance level of 0.01.  For these settings, the LRTae power was 0.544 and LRTstd 
power was 0.606.  The maximum power difference occurred whenC  for a 
dominant disease model with R
1000/ =gp C
2 = 3.5 and DAF = 0.07 at a significance level of 0.001.  
For these settings, the LRTae power was 0.910 and LRTstd power was 0.775. 
For the threshold double-sample selection method, the minimum power difference 
occurred when C  for a dominant disease model with R25/ =gp C 2 = 2 and DAF = 0.27 at 
a significance level of 0.05.  For these settings, the LRTae power was 0.821 and LRTstd 
power was 0.831.  The maximum power difference occurred whenC  for a 
dominant disease model with R
1000/ =gp C
2 = 2 and DAF = 0.07 at a significance level of 0.05.  For 
these settings, the LRTae power was 0.573 and LRTstd power was 0.411. 
 
Power difference as a function of double-sample proportion and cost ratio.  In 
the spirit of response surface analysis for factorial design (Box et al. 1978), we performed 
a more thorough analysis of the parameter settings that provided the maximum power 
difference when LRTae was computed with the random double-sample selection method.  
These parameter settings are a dominant disease model with R2 = 3.5 and DAF = 0.07.  
These settings provided the additional benefit of power results greater than 75% for both 
the LRTae and LRTstd methods at the 0.05, 0.01, and 0.001 significance levels for both 
cost ratios of C  and 25/ =gp C 1000/ =gp CC .  The analysis involved computation of 
the LRTae with the random double-sample selection method.  Figure 3.4 displays the two-
dimensional contour plots of the power difference between the LRTae and the LRTstd as a 
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function of r, the cost ratio of molecular haplotyping to genotyping, and α, the proportion 
of individuals double-sampled.  These power differences are computed for the fixed 
parameter settings of 25/ =gp CC  (Figure 3.4A) and 1000/ =gp CC  (Figure 3.4B) at 
significance level = 0.001 for the disease model described immediately above.  The 
values of r considered in the contour plots are 1, 5, 10, 25, and 50 while the values of α 
considered are 0.25, 0.50, 0.75, and 1.0.  One should note that α = 1.0 indicates all 
individuals in the study are double-sampled regardless of phase ambiguity.  Simulations 
were performed with 1000 replicates and 10,000 permutations for each combination of 
parameters, and SNPHAP v 1.3.1 was utilized for the haplotype inference.  The sample 
size for the LRTstd, N, was 1000 (equal numbers of cases and controls). 
 
 82
Figure 3.4  Contour plots of the power difference between LRTae and LRTstd at a significance level of 0.001 (two SNP scenario) 
 
Legend for Figure 3.4: The contour plots display the power difference between the LRTae and LRTstd at various settings for the cost ratio of 
molecular haplotyping to genotyping (r) and the proportion of individuals double-sampled (α).  Power is compared at the 0.001 significance level.  
The cost ratio of phenotyping to genotyping for (A) is 25 while the cost ratio of phenotyping to genotyping for (B) is 1000.  The two SNP scenario 
is examined for the parameter settings that provided the maximum power difference for factorial design (Table 3.2) using the random double-
sample selection method.  Generating haplotype frequencies for cases and controls were based on a dominant disease model with f = 0.025, 
R2 = 3.5, and DAF = 0.07, as well as, population haplotype frequencies of 0.05, 0.25, 0.15, and 0.55.  The haplotype with a frequency of 0.05 was 
placed in LD (D’ = 0.9) with the disease allele.  LRTae was only computed with the random double-sample selection method.  Haplotype pairs 
were inferred using SNPHAP v 1.3.1.  
Figure 3.4A shows that the LRTae provides a power advantage over the LRTstd 
when r is less than 10 and α is greater than 0.5.  The maximum power gain is 0.16 and 
occurs when r and α are 1.0.  Conversely, when r is greater than 10, LRTae is less 
powerful than LRTstd for these parameter settings.  The maximum power loss is 0.58 and 
occurs when r is 50 and α is 1.0.  Note that for these values the total sample available for 
the LRTae method, NDS (equation (1)), is 342 while the total sample available for the 
LRTstd method, N, is 1000. 
Figure 3.4B illustrates that LRTae is always at least as powerful as LRTstd when 
.  We observe a minimum power gain of 0.02 when r is 50 and α is 0.25 
and a maximum power gain of 0.17 when r and α are 1.0.  Furthermore, Figure 3.4B 
indicates that for any cost ratio, r, increasing the double-sampling proportion, α, always 
increases the power gain with the maximum power gain occurring when α = 1.0. 
1000/ =gp CC
Figures 3.5 and 3.6 display similar contour plots of the power difference between 
the LRTae and the LRTstd (as a function of r, the cost ratio of molecular haplotyping to 
genotyping, and α, the proportion of individuals double-sampled) using the same 
parameters as above at significance levels of 0.01 and 0.05, respectively.  Again, these 
power differences are computed for fixed parameter settings of 25/ =gp CC  
(Figures 3.5A and 3.6A) and 1000/ =gp CC  (Figures 3.5B and 3.6B).  Figures 3.5 and 
3.6 show that the results using significance thresholds of 0.01 and 0.05 are similar to 
those using a significance threshold of 0.001 (Figure 3.4).  When r is less than 10 (same 
as for Figure 3.4A), Figures 3.5A and 3.6A show that LRTae provides a power advantage 
over LRTstd.  As the significance level increases, the power advantage decreases.  Thus, 
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the power advantage is greatest for the 0.001 significance level, less for the 0.01 
significance level, and least for the 0.05 significance level.  Figures 3.5B and 3.6B 
illustrate that when 1000/ =gp CC , LRTae is always more powerful than LRTstd at 
significance levels of 0.01 and 0.05, respectively.  Again, the power advantage decreases  
as the significance level increases.
 85
Figure 3.5  Contour plots of the power difference between LRTae and LRTstd at a significance level of 0.01 (two SNP scenario) 
 
Legend for Figure 3.5: The contour plots display the power difference between LRTae and LRTstd at various settings for the cost ratio of molecular 
haplotyping to genotyping (r) and the proportion of individuals double-sampled (α).  Power is compared at the 0.01 significance level.  The cost 
ratio of phenotyping to genotyping for (A) is 25 while the cost ratio of phenotyping to genotyping for (B) is 1000.  The two SNP scenario is 
examined for the parameter settings that provided the maximum power difference for factorial design (Table 3.2) using the random double-sample 
selection method.  Generating haplotype frequencies for cases and controls were based on a dominant disease model with f = 0.025, R2 = 3.5, and 
DAF = 0.07, as well as, population haplotype frequencies of 0.05, 0.25, 0.15, and 0.55.  The haplotype with a frequency of 0.05 was placed in LD 
(D’ = 0.9) with the disease allele.  LRTae was only computed with the random double-sample selection method.  Haplotype pairs were inferred  
using SNPHAP v 1.3.1
Figure 3.6  Contour plots of the power difference between LRTae and LRTstd at a significance level of 0.05 (two SNP scenario) 
 
Legend for Figure 3.6: The contour plots display the power difference between LRTae and LRTstd at various settings for the cost ratio of molecular 
haplotyping to genotyping (r) and the proportion of individuals double-sampled (α).  Power is compared at the 0.05 significance level.  The cost 
ratio of phenotyping to genotyping for (A) is 25 while the cost ratio of phenotyping to genotyping for (B) is 1000.  The two SNP scenario is 
examined for the parameter settings that provided the maximum power difference for factorial design (Table 3.2) using the random double-sample 
selection method.  Generating haplotype frequencies for cases and controls were based on a dominant disease model with f = 0.025, R2 = 3.5, and 
DAF = 0.07, as well as, population haplotype frequencies of 0.05, 0.25, 0.15, and 0.55.  The haplotype with a frequency of 0.05 was placed in LD 
(D’ = 0.9) with the disease allele.  LRTae was only computed with the random double-sample selection method.  Haplotype pairs were inferred 
using SNPHAP v 1.3.1.  
Multi-SNP scenario 
Evaluation of false positive rates for permutation and asymptotic p-values.  
Table 3.4 displays our estimates of the false positive rate using various significance 
thresholds (0.05, 0.01, and 0.001) and the results of the KS test for the Horan and 
HapMap TAP2 dataset-based simulations.  Again, only the permuted p-values resemble 
the standard uniform distribution.  In addition, the permuted p-values maintain the 
nominal significance level while the asymptotic p-values are anti-conservative. 
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Table 3.4  False positive rate estimates for simulations with generating population 
haplotype frequencies based on the Horan and HAPMAP TAP2 datasets 















95% C.I. KS p-Value 
LRTstd N/A 0.396 (0.366, 0.427) < 0.001 0.424 (0.393, 0.455) < 0.001
random 0.500 (0.469, 0.532) < 0.001 0.659 (0.629, 0.688) < 0.001asymptotic LRTae threshold 0.490 (0.459, 0.522) < 0.001 0.632 (0.601, 0.662) < 0.001
LRTstd N/A 0.062 (0.048, 0.079) 0.931 0.041 (0.030, 0.055) 0.770 
random 0.053 (0.040, 0.069) 0.718 0.047 (0.035, 0.062) 0.665 
0.05 
permuted 
LRTae threshold 0.051 (0.038, 0.067) 0.143 0.048 (0.036, 0.063) 0.267 
LRTstd N/A 0.122 (0.102, 0.144) < 0.001 0.154 (0.132, 0.178) < 0.001
random 0.181 (0.158, 0.206) < 0.001 0.336 (0.307, 0.366) < 0.001asymptotic LRTae threshold 0.168 (0.145, 0.193) < 0.001 0.314 (0.285, 0.344) < 0.001
LRTstd N/A 0.014 (0.008, 0.023) 0.931 0.010 (0.005, 0.018) 0.770 
random 0.010 (0.005, 0.018) 0.718 0.008 (0.004, 0.016) 0.665 
0.01 
permuted 
LRTae threshold 0.004 (0.001, 0.010) 0.143 0.012 (0.006, 0.021) 0.267 
LRTstd N/A 0.020 (0.012, 0.031) < 0.001 0.013 (0.007, 0.022) < 0.001
random 0.033 (0.023, 0.046) < 0.001 0.062 (0.048, 0.079) < 0.001asymptotic LRTae threshold 0.026 (0.017, 0.038) < 0.001 0.070 (0.055, 0.088) < 0.001
LRTstd N/A 0.003 (0.001, 0.009) 0.931 0.004 (0.001, 0.010) 0.770 
random 0.003 (0.001, 0.009) 0.718 0.002 (0.000, 0.007) 0.665 
0.001 
permuted 
LRTae threshold 0.001 (0.000, 0.006) 0.143 0.000 (0.000, 0.003) 0.267 
 
Legend for Table 3.4: This table presents estimates of the false positive rate and the 
corresponding 95% confidence intervals for the LRTstd and LRTae statistics (asymptotic and 
permuted p-values) for various significance levels.  The generating population haplotype 
frequencies for the simulations were based on the Horan and HAPMAP TAP2 datasets (as 
described extensively in the Methods section).  Simulations for 1000 replicate datasets containing 
250 cases and 250 controls were performed.  LRTae was computed with the random and threshold 
double-sample selection methods.  When the random double-sample selection method was 
utilized, a setting of α = 0.75 was used.  When the threshold double-sample method was utilized 
to compute LRTae, the setting of δ = 0.85 was used, and the maximum proportion of individuals 
included in the double-sample was 0.75.  The table also displays p-values for the Kolmogorov-
Smirnov Test (KS Test) which tests the null hypothesis that the p-values computed for each 
statistic are drawn from a standard uniform distribution.  Haplotype pairs were inferred using 
SNPHAP v 1.3.1. 
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Evaluation of power for fixed cost.  In our power study for haplotypes comprised 
of five SNPs, we again utilized the disease model parameter settings that provided the 
maximum power difference (LRTae power – LRTstd power) for the two SNP factorial 
design (Table 3.2) with LRTae computed using random double-sample selection.  These 
parameter settings are a dominant disease model with R2 = 3.5 and DAF = 0.07.  We 
based the population haplotype frequencies on the Horan and HapMap TAP2 datasets as 
described in the Methods section.  For each dataset, we selected the haplotype with a 
frequency closest to 0.05 as the haplotype in LD with the disease allele.  By this choice of 
haplotype, we approximated the frequency of the linked haplotype for the two SNP 
scenario (see section 3.2) when DAF = 0.07.  As with two SNP power study, the LD 
between the disease allele and the linked haplotype was 0.9 (measured by D’) (Lewontin 
1964).   The cost ratio of molecular haplotyping to genotyping (r) was 5.  When the 
random double-sample selection method was utilized to compute LRTae, the double-
sample proportion (α) was 0.75.  When the threshold double-sample method was utilized 
to compute LRTae, the setting of δ = 0.85 was used, and the maximum proportion of 
individuals included in the double-sample was 0.75. 
For the Horan dataset, the power estimates for LRTstd and LRTae were almost 
identical at the 0.05, 0.01, and 0.001 significance levels for cost ratios (C ) of both 
1000 and 25 (results not shown).  The high pair-wise intermarker LD present in the 
Horan dataset causes the haplotype inference to occur with almost complete fidelity.  In 
the absence of misclassification, the LRT
gp C/
ae statistic reduces to LRTstd.  Therefore, the 
high degree of similarity in power for these statistics is not surprising. 
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For the HAPMAP TAP2 dataset, Table 3.5 displays the power estimates and the 
corresponding 95% confidence intervals for the LRTstd and LRTae methods at the 0.05, 
0.01, and 0.001 significance levels assuming fixed costs.  When C , LRT1000/ =gp C ae 
provides a substantial power benefit over LRTstd with the power difference ranging from 
6% and 7% at a significance level of 0.05 to 14% and 21% at a significance level of 
0.001 for random double-sample selection and threshold double-sample selection, 
respectively.  When 25/ =gp CC , the advantage of LRTae over LRTstd is still substantial 
for threshold double-sample selection but more modest for random double-sample 
selection.  For the three significance levels under investigation, the power difference 
ranged from 7% to 22% and 1% to 3.5% for threshold and random double-sample 
selection, respectively.  
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Table 3.5  Power estimates for simulations with generating population haplotype 






Cp/Cg Power 95% C.I. 
LRTstd N/A N/A 0.858 (0.835, 0.879) 
1000 0.919 (0.900, 0.935) 
random
25 0.868 (0.845, 0.888) 




25 0.935 (0.918, 0.950) 
LRTstd N/A N/A 0.666 (0.636, 0.695) 
1000 0.801 (0.775, 0.825) 
random
25 0.701 (0.672, 0.729) 




25 0.817 (0.792, 0.841) 
LRTstd N/A N/A 0.405 (0.374, 0.436) 
1000 0.546 (0.515, 0.577) 
random
25 0.421 (0.390, 0.452) 




25 0.626 (0.595, 0.656) 
 
Legend for Table 3.5: This table presents power estimates and the corresponding 95% confidence 
intervals for LRTstd and LRTae statistics (permuted p-values) at various significance levels.  The 
simulations were performed under fixed costs such that the number of samples when LRTae is 
applied is reduced according to equation (3.6).  The generating population haplotype frequencies 
for the simulations were based on the HAPMAP TAP2 dataset (as described extensively in the 
Methods section).  The disease model is dominant with R2 = 3.5, disease prevalence = 0.025, 
DAF = 0.07, and D’ between the disease allele and the associated haplotype = 0.9.  Settings of 
α = 0.75 (random double-sample selection method) and r = 5 were used.  When the threshold 
double-sample method was utilized to compute LRTae, the setting of δ = 0.85 was used, and the 
maximum proportion of individuals included in the double-sample was 0.75.  Haplotype pairs 
were inferred using SNPHAP v 1.3.1. 
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We found that the median power gain of LRTae over LRTstd for the threshold 
double-sample selection method was consistently greater than that for the random 
double-sample selection method for the runs associated with the factorial design settings 
displayed in Table 3.2 and the HAPMAP TAP2 power simulations (see Tables 3.3 and 
3.5).  Furthermore, the power gain for the threshold double-sample selection method 
occurred for either setting of C .  For the threshold double-sample selection method, gp C/
α  was small (less than 21%) in our simulations so that our computed NDS* corresponded 
to 963 individuals. 
Power difference as a function of double-sample proportion and cost ratio.  As 
we did for the two SNP scenario, we performed a more thorough analysis to explore the 
effect of varying the cost ratio of molecular haplotyping to genotyping (r) and the double-
sample proportion (α) on the power difference between LRTae and LRTstd for the multi-
SNP scenario.  Again, we used the parameter settings of a dominant disease model with 
R2 = 3.5 and DAF = 0.07.  As before, f was set to 0.025, and the haplotype with a 
frequency closest to 0.05 was placed in LD (D’ = 0.9) with the disease allele.  The 
population haplotype frequencies were those from the HAPMAP TAP2 dataset 
(haplotype comprising 5 SNPs).  The analysis involved computation of LRTae with the 
random double-sample selection method.  Figures 3.7, 3.8, and 3.9 display the two-
dimensional contour plots of the power difference between LRTae and LRTstd as a 
function of r and α at significance levels of 0.001, 0.01, and 0.05, respectively.  These 
power differences are computed for the fixed parameter settings of 25/ =gp CC  
(Figures 3.7A, 3.8A, and 3.9A) and 1000/ =gp CC (Figures 3.7B, 3.8B, and 3.9B).  The 
values of r considered in the contour plots are 1, 5, 10, 25, and 50 while the values of α 
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considered are 0.25, 0.50, 0.75, and 1.0.  Simulations were performed with 1000 
replicates and 1000 permutations for each combination of parameters, and 
SNPHAP v 1.3.1 was utilized for the haplotype inference.  The sample size for LRTstd, N, 
was 1000 (equal numbers of cases and controls). 
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Figure 3.7  Contour plots of the power difference between LRTae and LRTstd at a significance level of 0.001 (multi-SNP scenario) 
 
Legend for Figure 3.7: The contour plots display the power difference between LRTae and LRTstd at various settings for the cost ratio of molecular 
haplotyping to genotyping (r) and the proportion of individuals double-sampled (α).  Power is compared at the 0.001 significance level.  The cost 
ratio of phenotyping to genotyping for (A) is 25 while the cost ratio of phenotyping to genotyping for (B) is 1000.  Generating haplotype 
frequencies for cases and controls were based on a dominant disease model with f = 0.025, R2 = 3.5, and DAF = 0.07, as well as, population 
haplotype frequencies found from the HAPMAP TAP2 dataset (haplotype comprising 5 SNPs).  The haplotype with a frequency closest to 0.05 
was placed in LD (D’ = 0.9) with the disease allele.  LRTae was only computed with the random double-sample selection method.  Haplotype pairs 
were inferred using SNPHAP v 1.3.1. 
Figure 3.8  Contour plots of the power difference between LRTae and LRTstd at a significance level of 0.01 (multi-SNP scenario) 
 
Legend for Figure 3.8: The contour plots display the power difference between LRTae and LRTstd at various settings for the cost ratio of molecular 
haplotyping to genotyping (r) and the proportion of individuals double-sampled (α).  Power is compared at the 0.01 significance level.  The cost 
ratio of phenotyping to genotyping for (A) is 25 while the cost ratio of phenotyping to genotyping for (B) is 1000.  Generating haplotype 
frequencies for cases and controls were based on a dominant disease model with f = 0.025, R2 = 3.5, and DAF = 0.07, as well as, population 
haplotype frequencies found from the HAPMAP TAP2 dataset (haplotype comprising 5 SNPs).  The haplotype with a frequency closest to 0.05 
was placed in LD (D’ = 0.9) with the disease allele.  LRTae was only computed with the random double-sample selection method.  Haplotype pairs 
were inferred using SNPHAP v 1.3.1.  
Figure 3.9  Contour plots of the power difference between LRTae and LRTstd at a significance level of 0.05 (multi-SNP scenario) 
 
Legend for Figure 3.9: The contour plots display the power difference between LRTae and LRTstd at various settings for the cost ratio of molecular 
haplotyping to genotyping (r) and the proportion of individuals double-sampled (α).  Power is compared at the 0.05 significance level.  The cost 
ratio of phenotyping to genotyping for (A) is 25 while the cost ratio of phenotyping to genotyping for (B) is 1000.  Generating haplotype 
frequencies for cases and controls were based on a dominant disease model with f = 0.025, R2 = 3.5, and DAF = 0.07, as well as, population 
haplotype frequencies found from the HAPMAP TAP2 dataset (haplotype comprising 5 SNPs).  The haplotype with a frequency closest to 0.05 
was placed in LD (D’ = 0.9) with the disease allele.  LRTae was only computed with the random double-sample selection method.  Haplotype pairs  
were inferred using SNPHAP v 1.3.
Like the two SNP scenario, Figures 3.7, 3.8, and 3.9 illustrate that for the multi-
SNP scenario the power difference between LRTae and LRTstd increases as the 
significance threshold decreases.  Figures 3.7A, 3.8A, and 3.9A show that LRTae 
provides a power advantage over LRTstd when r is less than 5 and α is greater than 0.5 
when significance thresholds of 0.001, 0.01, and 0.05, respectively, are applied.  In each 
case a maximum power gain (0.182 for the 0.001 significance level, 0.153 for the 0.01 
significance level, and 0.084 for the 0.05 significance level) occurs when r and α are 1.0.  
Conversely, when the r is greater than 5, LRTae is less powerful than LRTstd for these 
parameter settings. 
Figures 3.7B, 3.8B, and 3.9B show that LRTae is almost always at least as 
powerful as LRTstd when 1000/ =gp CC  for the multi-SNP scenario.  We observe a 
slight power loss of 0.02 at the 0.001 significance level when α = 0.25 and r = 10 and of 
approximately 0.01 at the 0.01 and 0.05 significance levels when α = 0.25 and r = 5.  The 
maximum power gain of 0.217 occurs when r and α are 1.0 using a significance threshold 
of 0.001 (Figure 3.7B).  As we observed with the two SNP scenario, Figures 3.7B, 3.8B, 
and 3.9B indicate that for any cost ratio, r, increasing the double-sampling proportion, α, 
always increases the power gain with the maximum power gain occurring when α = 1.0.   
Furthermore, comparing the multi-SNP scenario (Figures 3.7, 3.8, and 3.9) with 
the two SNP scenario (Figures 3.4, 3.5, and 3.6), we find the same fundamental trends for 
both and 25=gp C/C 1000/ =gp CC .  However, the multi-SNP scenario generally 
displays a larger power advantage for LRTae over LRTstd due to the greater opportunity 
for misclassification of haplotypes composed of more double heterozygotes. 
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3.4 Discussion 
In practice, few researchers employ molecular haplotyping techniques in genetic 
case-control studies.  The absence of a high-throughput procedure relative to current SNP 
genotyping technologies is arguably the main reason that this methodology is not more 
widely used.  Another related reason is the cost in terms of both time and money 
associated with employing this methodology.  Our research suggests that the additional 
costs involved in molecular haplotyping may be worth the effort, especially if the cost of 
phenotyping is high relative to the cost of genotyping for a study.  Ji et al. found 
analogous results for the effects of genotype misclassification on genotypic tests of 
association (Ji et al. 2005).  Other research has shown that molecular haplotypes can 
greatly increase the power of family-based linkage studies for mapping complex diseases 
(Gillanders et al. 2006).  In practice, the situation where the cost of phenotyping is high 
relative to the cost of genotyping arises for replication studies.  A genome-wide scan 
involving thousands of SNP markers along with subsequent fine mapping in an initial set 
of case and control individuals may identify a number of promising regions for follow-up 
studies.  These follow-up or replication studies involve recruiting an independent sample 
of cases and controls for which only SNPs in the promising regions will be genotyped 
(Skol et al. 2006).  In replication studies for complex traits, the cost ratio of phenotyping 
to genotyping may be on the order of thousands.  For these situations, the LRTae for 
testing haplotype association should provide the most utility.  It is interesting to note, 
however, that applying the threshold double-sample selection method provided 
comparable powers for both high and low phenotyping to genotyping cost ratios.  This 
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finding suggests that this selection strategy may provide additional power for an initial 
genome-wide association study as well as for a replication study. 
One potential limitation of the test statistics that we selected is the increase in 
degrees of freedom associated with using haplotype pairs rather than individual 
haplotypes.  In general, larger degrees of freedom may result in a loss of power.  That is, 
methods that fully account for uncertainty in the phase assignment process (Schaid et al. 
2002; Zaykin et al. 2002; Stram et al. 2003) may be more powerful than LRTae because 
the LRTae method examines haplotype pairs rather than single haplotypes and therefore 
has more degrees of freedom.  We chose these statistics for the following reasons: 1) The 
most general misclassification model involves modeling errors in haplotype pairs rather 
than in individual haplotypes (Douglas et al. 2002; Sobel et al. 2002; Gordon et al. 2004).  
2) When haplotype pair frequencies deviate from Hardy Weinberg Equilibrium in either 
case or control sample populations, test statistics that utilize single haplotype frequencies 
may increase false positive rates and/or lose power (Sasieni 1997; Czika and Weir 2004).  
3) In contrast with methods that utilize single haplotype frequencies, the Cochran-
Armitage Linear Test of Trend maintains the nominal false positive rate and does not lose 
power (Cochran 1954; Armitage 1955; Czika and Weir 2004).  To our knowledge, a 
version of this test that incorporates double-sampling procedures to correct for haplotype 
miscalls does not currently exist. 
A point for further research involves identifying the scenarios that produce 
differential and non-differential haplotype pair misclassification as well as the effects of 
each kind of misclassification on type I error and power.  Under the null hypothesis that 
haplotype frequency distributions are equal in case and control populations, theoretical 
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and simulation studies (including the work presented in this chapter) suggest that 
misclassification is non-differential.  Under the alternative hypothesis, it is conceivable 
that haplotype pair misclassification rates may be different in case and control 
populations.  While recent research (Clayton et al. 2005; Moskvina et al. 2006) indicates 
that differential misclassification increases the type I error, the effects of differential 
misclassification on the power of these statistics remain unclear.  
While the current perception may be that molecular haplotyping costs are not 
cost-effective, recent publications suggest that for relatively small regions of the genome 
accurate molecular haplotyping is no more expensive than performing fluorescent 
polymerase chain reactions (Proudnikov et al. 2004; Proudnikov et al. 2006).  In addition, 
current techniques are able to provide molecular haplotypes for an entire chromosome at 
a cost ratio (Cmh/Cg) of approximately 5 (C. Ding; personal communication).  Finally, as 
technology improves, the costs associated with molecular haplotyping will likely 
decrease, and the throughput will likely increase. 
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CHAPTER 4:  ASCERTAINING THE DISTRIBUTION FOR THE 
LIKELIHOOD RATIO STATISTIC 
 
4.1 Introduction 
Although haplotype misclassification can decrease the power for a study, the issue 
can be avoided by applying an approach that does not infer haplotype pairs for each study 
participant.  An alternative approach is to employ a test statistic that relies on haplotype 
frequency estimates rather than haplotype calls.  Besides the consequences of estimates 
deviating from their true values, this alternative approach faces complications of its own.  
In some situations, the exact distribution of the test statistic under both the null and 
alternative hypotheses can be unclear. 
Haplotype-based studies are often hindered by the fact that some haplotypes occur 
very rarely.  The number of possible haplotypes grows exponentially as the number of 
component SNP loci increases.  Consequently, the number of possible haplotypes is often 
quite large, and many of these possible haplotypes are rare or do not appear at all in the 
population.  Recent studies have found that haplotypes appear in blocks such that there 
are several common variants while many other variants do not appear at all or are very 
rare (Daly et al. 2001; Patil et al. 2001; Stephens et al. 2001a; Subrahmanyan et al. 2001; 
Gabriel et al. 2002; International HapMap Consortium 2003; International HapMap 
Consortium 2005).  As mentioned earlier, several strategies, such as clustering based on 
similarity (Hoehe et al. 2000), pooling rare haplotypes (Sham and Curtis 1995; Schaid et 
al. 2002; Zhao et al. 2003), and applying haplotype diversity criteria for SNP selection 
(Johnson et al. 2001; Jannot et al. 2004) 
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(http://www-gene.cimr.cam.ac.uk/clayton/software/stata/htSNP/htsnp.pdf), have been 
utilized to reduce the number of haplotype categories and potentially to gain power.  
However, rare or non-existent haplotypes can have other effects on an analysis besides a 
reduction in power. 
Since multilocus genotypes lack phase information, the testing situation for 
haplotype-based association studies is more complex than that for other genetic 
association studies where the variants under investigation are directly observed.  In tests 
of haplotype-based association where haplotype frequencies are estimated from 
multilocus genotypes, estimation procedures may find a small frequency for some 
haplotypic variants.  There is uncertainty whether haplotypes with small frequency 
estimates are present but rare in the sample or not present in the sample at all but merely 
compatible with the multilocus genotypes observed.  The effect of this situation on the 
distribution of the resulting test statistic under both null and alternative hypotheses 
remains unclear.  One still expects that the test statistic will follow a central χ2 
distribution under H0 and a noncentral χ2 distribution under H1.  However, the degrees of 
freedom associated with either χ2 distribution are no longer well defined.   
In this work, we investigate the distribution of a test statistic which relies on 
haplotype frequency estimates to detect an association between a haplotype and disease 
status.  In particular, we are interested in the distribution of this statistic when some 
haplotypic variants are extremely rare or nonexistent.  Furthermore, we apply a rule to 




Test statistic.  We considered a likelihood ratio statistic for detecting haplotype-
based association with disease.  The null hypothesis we test is  for all 
haplotypes 
j*jj hhh:H == 100
j  while the alternative hypothesis is jj hh:H 101 ≠  for at least one j where 
, , and  are the haplotype frequencies for cases, controls, and the entire 
population, respectively, for the j
jh0 jh1 jh∗

















lnLRT       (4.1) 
where and are the likelihood of the data under the alternative and null 
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where N is the number of individuals genotyped, Hi is the set of haplotype pairs 
compatible with the ith multilocus genotype, and and are haplotype frequencies for 





th multilocus genotype.  Expressing these likelihoods 
in terms of the haplotype frequencies (equation (4.2)), we have a missing data problem 
(since we do not observe phase directly).  However, we can overcome this hurdle by 
applying the EM algorithm (Dempster et al. 1977) to find these likelihoods and estimates 
of  the haplotype frequencies.  We implement this strategy by employing the software 
package EHP (see Electronic Resource Information).  This software was developed to 
compute haplotype frequency estimates for datasets where the DNA samples from 
several individuals have been pooled together.  However, since our analysis did not 
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require any pooling of samples, we set our pool size to one.  Equation (4.1) can be 
rewritten as: 
[ ] [ ] [ ][ ]∗−+×= LlnLlnLlnLRT 102     (4.3) 
where , , and  are the likelihoods computed from the multilocus genotypes from 
cases alone, controls alone, and all samples, respectively.  The reader should note that  






0 since the haplotype frequencies must be equal for 
cases and controls.  In addition, the product of  and  represents the likelihood under 
H
0L 1L
1 since the haplotype frequencies for cases and controls are unconstrained.  Applying 
the EM algorithm (Dempster et al. 1977) as implemented in EHP, we computed , , 




ae and LRTstd described in the previous chapter, we will refer to it as 
LRTem from this point forward. 
 
Description of data generation and analysis.   To investigate the distribution of 
the LRT statistic for a variety of situations, we applied LRTem to many simulated datasets.  
Figure 4.1 illustrates the procedure we used to simulate the data and compute the LRTem 
statistic under the null and alternative hypotheses.  For each replicate dataset, we 
simulated haplotype pairs for each individual from known frequencies (population 
haplotype frequencies under H0 and conditional haplotype frequencies under H1).  Next 
we removed the phase information for each individual.  We utilized the remaining 
multilocus genotypes to compute the LRTem statistic using the EHP software as described 
above.  After all replicate datasets had been simulated, we examined the distribution of 
the resulting LRTem statistics.  In order to find the distribution from which the LRTem 
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statistics derive, we performed a goodness-of-fit test, the Kolmogorov-Smirnov (KS) test, 
for χ2 distributions with various degrees of freedom.  Since all KS tests in this chapter are 
for χ2 distributions, we use the notation KSv, j to indicate a KS test for a χ2 distribution 
with noncentral parameter, v, and degrees of freedom, j.  In addition, we visually 
compared distributional plots of the LRTem statistic with several χ2 distributions with 
various degrees of freedom. 
Figure 4.1  Schematic flow chart illustrating the procedure for data simulation and 
analysis 
Use EM algorithm (as implemented 
in the EHP software) to calculate 
the likelihood and estimate 
haplotype frequencies from the 
multilocus genotypes for cases 
separately, controls separately, 





Examine the distribution of the LRT statistics after all replicates completed 




Simulate haplotypes from known population frequencies 
and arbitrarily assign to cases and controls.A)
Simulate haplotypes from known frequencies 
(conditional on affection status).  These conditional 









Legend for Figure 4.1:  This schematic flow chart illustrates the procedure employed to create a 
distribution of LRTem statistics under (A) the null hypothesis and (B) the alternative hypothesis by 
way of data simulation. 
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Two SNP scenario 
Examination of the distributional properties of LRTem under the null 
hypothesis.  As in chapter 3, for the simplest non-trivial case, the scenario where the 
haplotype under evaluation includes two SNPs, we applied a factorial design (Box et al. 
1978).  Here we utilized the factorial design to perform a comprehensive study of the 
distributional properties of LRTem.  Table 4.1 contains the factorial design settings for the 
scenario involving two SNP markers.  We consider a  factorial design, where g = 4.  
We reduced the number of experimental runs from 16 to 12 due to redundancy.  For 
example, a run with a haplotype comprised of a SNP with minor allele frequency 0.5 at 
the locus 1 and a SNP with minor allele frequency 0.01 at locus 2 is equivalent to a run 
with a haplotype comprised of a SNP with minor allele frequency 0.01 at locus 1 and a 
SNP with minor allele frequency 0.5 at locus 2 (with all other factors having equal 
settings to those for the first run).  Since minor allele frequencies of 0.05 and 0.01 are 
commonly used thresholds for SNP selection in association studies, we chose 0.01 (the 
more extreme threshold) as the low setting for the minor allele frequency at loci 1 and 2.  
Within each replicate dataset, the number of cases and controls were equal.  During each 





Table 4.1  Factorial design parameter settings assuming the haplotype under 
investigation contains two SNP markers 
Description of parameter Low High 
Number of subjects (equal cases and controls) 500 2000 
Minor allele frequency at locus 1 (MAF1) 0.01 0.5 
Minor allele frequency at locus 2  (MAF2) 0.01 0.5 
LD between locus 1 and 2 (measured by D’) 0 0.9 
 
Legend for Table 4.1: This table presents the settings for all parameters considered in the 
simulations to study the distribution of LRTem under H0 and H1 assuming the haplotype under 
investigation contains two SNP markers.  We consider a 2  factorial design, where g = 4.  The 
number of experimental runs was reduced from 16 to 12 due to redundancy.  D’ is the 
standardized linkage disequilibrium measure.  The simulations included 10,000 replicates, and 




Examination of the distributional properties of LRTem under the alternative 
hypothesis.  We also examined the distribution of the LRTem statistics under the 
hypothesis that a disease allele at an unobserved locus exists in linkage disequilibrium 
(LD) with the haplotype under study.  Table 4.1 contains the factorial design settings for 
the study of the distribution of LRTem under H1.  As for the study under H0, the allele 
frequencies at each marker locus and the LD between marker loci were used to determine 
the population haplotype frequencies.  For the study under H0, these haplotype 
frequencies were used directly to simulate haplotypes.  However, for the study under H1, 
we used the population haplotype frequencies to compute the conditional (on case status) 
haplotype frequencies.  These conditional haplotype frequencies were then used, in turn, 
to simulate haplotypes for case and control individuals.  Conditional haplotype 
frequencies were found from population haplotype frequencies and specified disease 
model parameters by a method described by Sham and subsequently by De La Vega et al. 
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(Sham 1998; De La Vega et al. 2005) (also see the Power for Association with Error 
(PAWE) website at http://linkage.rockefeller.edu/derek/pawe1.html).  However, we 
selected a specific haplotype to be in LD with the disease allele.  For completeness, 
details regarding the conditional haplotype frequencies including notation and 
computation as described by De La Vega et al. (2005) are provided in subsection 3.2 of 
chapter 3.  For all runs under H1, the generating haplotype frequencies for cases and 
controls were based on a dominant disease model ( 12 RR = ) with f = 0.025, R2 = 3.5, and 
DAF = 0.07.  In addition, the marker haplotype with a frequency closest to 0.05 was 
placed in LD (D’ = 0.9) with the disease allele.  (In the previous chapter, we utilized 
these disease parameter settings for the in-depth power analysis for both the two SNP and 
multi-SNP scenarios.)  Subsection 3.2 also provides an example of how the conditional 
frequencies are computed.  As for the study under H0, we reduced the number of 
experimental runs from 16 to 12 due to redundancy.  Again, the number of cases and 
controls were equal within each replicate dataset, and 10,000 replicate datasets were 
simulated during each run. 
 
Multi-SNP scenario 
Examination of the distributional properties of LRTem under the null and 
alternative hypotheses.  We performed additional simulations to investigate the 
distributional properties of LRTem when applied to haplotypes comprised of larger 
numbers of SNPs.  Table 4.2 contains the factorial design settings for the study of the 
distribution of LRTem under H0 and H1 when the haplotype under investigation contains 
many SNPs.  Our simulations were based on haplotype frequencies from two datasets—
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the Horan (Horan et al. 2003) and HapMap TAP2 (International HapMap Consortium 
2003; International HapMap Consortium 2005) datasets.  The datasets are described in 
subsection 3.2 of chapter 3 along with an explanation of how the generating population 
haplotype frequencies were attained from each dataset.  Also in subsection 3.2, Figure 3.2 
displays the inter-marker LD present in each dataset.  For the experimental runs (both 
under H0 and H1) based on these datasets, we simulated haplotypes comprised of five and 
ten SNPs.  In Figure 3.2, the five SNP markers comprising the five-SNP haplotype are 
indicated with an asterisk (*) for both Horan and HAPMAP TAP2 datasets.  For the 
experimental runs with the ten-SNP haplotype, we used the last ten SNP markers 
appearing in Figure 3.2A for the Horan dataset, and all ten SNP markers appearing in 
Figure 3.2B for the HAPMAP TAP2 dataset.  The number of cases and controls were 




Table 4.2  Factorial design parameter settings assuming the haplotype under 
investigation contains many SNP markers 
Description of parameter Low High 
Inter-marker LD HAPMAP TAP2 Horan 
Number of SNPs comprising haplotype 5 10 
Number of subjects (equal cases and controls) 500 2000 
 
Legend for Table 4.2: This table presents the settings for all parameters considered in the 
simulations to study the distribution of LRTem under H0 and H1 assuming the haplotype under 
investigation contains many (more than two) SNP markers.  We consider a  factorial design, 
where g = 3.  Simulations were based on population haplotype frequencies from a dataset with 
low inter-marker LD, the Horan dataset (Horan et al. 2003), and on population haplotype 
frequencies from a dataset with high inter-marker LD, the HAPMAP TAP2 dataset (International 
HapMap Consortium 2003; International HapMap Consortium 2005).  The simulations included 





Predicting the degrees of freedom.  One goal of this work is to establish a “rule 
of thumb” for predicting the degrees of freedom for the χ2 distribution which most 
closely resembles the distribution of LRTem for a set of simulation parameters.  The rule 
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In equation (4.4), df is the predicted number of degrees of freedom for the χ2 distribution; 
J is the total number of possible haplotypes; , , and  are frequency estimates for jĥ0 jĥ1 jĥ∗
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the jth haplotype using cases alone, controls alone, and all samples, respectively; and t , 
, and t  are the number of cases, the number of controls, and the total number of 





According to statistical theory, for large sample sizes the LRTem statistic 
asymptotically follows a central χ2 distribution under H0 and a noncentral χ2 distribution 
under H1 (Mitra 1958; Hogg and Craig 1995; Agresti 1996). The number of degrees of 
freedom associated with either χ2 distribution equals the difference between the number 
of free parameters estimated under H1 and H0 in equation (4.1).  For LRTem in the context 
of haplotype-based association, this quantity can be expressed as  
110 −−+= *df ηηη      (4.5) 
where η , 1η , and ∗η  are the number of haplotypes estimated using cases alone, controls 
alone, and all samples, respectively.  The rule described above in equation (4.4) examines 
how 0η , 1η , and ∗η  should be found.  Suppose we estimate haplotype frequencies from 
multilocus genotypes from t individuals.  A single individual possessing one copy of the 
variant represents the minimum frequency of a haplotypic variant present in this sample.  
Thus, the rule described in equation (4.4) applies this minimum frequency ( t21 ) as a 
threshold to distinguish haplotypes present in the sample from those that are not present.   
To test the performance of this rule, we computed the average values for , , 
and  over all replicate datasets for cases alone, controls alone, and all samples together 
and computed the predicted degrees of freedom using equation (4.4).  We rounded the 
value computed for df and plotted the χ
jx∗
jx1
2 distribution with df degrees of freedom (along 
with χ2 distributions with df –1 and df +1) for comparison with the distribution LRTem.   
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The software package R (see Electronic Resource Information) was used to create these 
plots.  The noncentrality parameter (ncp) for the “predicted” χ2 distribution was 





























12      (4.6) 
as described by others (see http://linkage.rockefeller.edu/derek/pawe2.html) (Mitra 1958; 
Sham 1998; Gordon et al. 2002).  Under the null hypothesis, ncp = 0 since  and  




At the end of section 4.3, Table 4.3 summarizes the results for all experimental 
runs (both two SNP and multi-SNP scenarios under H0 and H1) presented in this chapter. 
 
Two SNP scenario. 
Examination of the distributional properties of LRTem under the null 
hypothesis.  Our simulation results under the null hypothesis can be classified into three 
categories—1) experimental runs where the rule described in equation (4.4) successfully 
predicts the correct distribution; 2) experimental runs where the rule described in 
equation (4.4) successfully predicts the correct distribution for larger sample sizes only; 
and 3) experimental runs where the rule described in equation (4.4) fails to predict the 
correct distribution regardless of sample size.  Figure 4.2 displays the distribution of 
LRTem for simulation runs that represent each of these categories.  In our factorial design 
(Table 4.1), some experimental runs contain no rare haplotypes in the generating 
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haplotype frequencies.  One example is the run in which MAF1 = 0.5, MAF2 = 0.5, and 
the LD between locus 1 and 2 (measured by D’) is 0.  These parameter settings result in 
four haplotypes with equal frequencies (0.25).  These frequencies serve as the generating 
frequencies for the simulation.  Figure 4.2A displays a histogram and density line for the 
LRTem statistic computed from simulations utilizing these parameter settings under H0 for 
500 samples (equal numbers of cases and controls).  Figure 4.2A shows that the 
distribution of LRTem for this experimental run closely resembles a central χ2 distribution 
with 3 degrees of freedom, the distribution predicted by the rule in equation (4.4).  Since 
all the generating haplotype frequencies are large, we expected LRTem for this run to 
exhibit this behavior.  For this run, the KS0,3 test (testing a central χ2 distribution with 
df = 3) p-value = 0.248 indicating that the distribution of LRTem is consistent with a 
central χ2 distribution with 3 degrees of freedom.  The experimental run with the same 




Figure 4.2  Histograms displaying the distribution of LRTem under H0 for the two SNP 
scenario 
 
Legend for Figure 4.2: The histograms display the distribution of LRTem along with the density 
lines for several central χ2 distributions for a number of experimental runs.  The distribution of 
LRTem was created by simulating haplotypes comprised of two SNPs under H0.  For (A), 
MAF1 = 0.5 and MAF2 = 0.5; for (B and C), MAF1 = 0.5 and MAF2 = 0.01; and for (D) 
MAF1 = 0.01 and MAF2 = 0.01.  For all runs displayed, LD between SNP 1 and 2 = 0 (measured 
by D’).  10,000 replicate datasets comprised of 500 samples (A and B) and 2000 samples (C and 
D) were simulated.  The graphs were scaled to the observed data, and density lines off the scale 
were truncated. 
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Other experimental runs required larger sample sizes for the rule described in 
equation (4.4) to predict the correct distribution.  The experimental run in which 
MAF1 = 0.5, MAF2 = 0.01, and LD between locus 1 and 2 = 0 (measured by D’) exhibited 
this behavior.  This run had a minimum generating haplotype frequency (0.005) that was 
substantially smaller than the minimum generating haplotype frequency for the run 
described above yet still greater than any of the thresholds established by the rule 
described in equation (4.4).  Figures 4.2B and 4.2C display histograms for LRTem 
computed from simulations utilizing these parameter settings.  Figure 4.2B shows the 
distribution for simulated datasets containing 500 samples while Figure 4.2C shows the 
distribution for simulated datasets containing 2000 samples.  In Figure 4.2B, the 
distribution of LRTem does not resemble a central χ2 distribution with 2 degrees of 
freedom, the distribution predicted by the rule in equation (4.4) for this run.  Instead, it 
roughly resembles a central χ2 distribution with 3 degrees of freedom.  Figure 4.2C 
shows that increasing the sample size leads to a better fit with a central χ2 distribution 
with 3 degrees of freedom, the distribution predicted with the increased sample size using 
the rule described in equation (4.4).  Although the distribution of LRTem visually matches 
the density plot for the central χ2 distribution with 3 degrees of freedom in Figure 4.2C, 
the KS0,3 p-values for both the 500 and 2000 sample size runs are approximately 0.  Thus, 
the distribution of LRTem for the 2000 sample run still deviates from a central χ2 
distribution with 3 degrees of freedom. 
The rule described in equation (4.4) failed to predict the distribution for other 
experimental runs regardless of the sample size.  The experimental run in which 
MAF1 = 0.01, MAF2 = 0.01, and LD between locus 1 and 2 = 0 (measured by D’) is in 
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this category.  This run had a minimum generating haplotype frequency (0.0001) that was 
below all of the thresholds (for both a sample size of 500 and 2000) established by the 
rule described in equation (4.4).  Figure 4.2D displays a histogram for LRTem computed 
from simulations utilizing these parameter settings.  Figure 4.2D shows the distribution 
for simulated datasets containing 2000 samples.  In Figure 4.2D, the distribution of 
LRTem does not resemble a central χ2 distribution with 2 degrees of freedom, the 
distribution predicted by the rule in equation (4.4) for this experimental run.  Instead, the 
distribution of LRTem falls between central χ2 distributions with 2 and 3 degrees of 
freedom.  The distribution of LRTem utilizing the same parameters for simulating datasets 
with 500 samples exhibited near identical behavior (results not shown).  Thus, in this 
case, increasing the sample size did not increase the accuracy of the prediction rule 
described in equation (4.4). 
 
Examination of the distributional properties of LRTem under the alternative 
hypothesis.  The prediction rule in equation (4.4) was not as successful for our 
simulations under the alternative hypothesis for the two SNP scenario.  Although for the 
majority of cases the distribution of LRTem did not resemble the distribution selected by 
the rule, in some situations increasing the sample size provided a distribution of LRTem 
predicted by the rule (as we observed under H0).  Figures 4.3A and 4.3B display the 
distribution of LRTem for one such set of experimental runs.  Here MAF1 = 0.5, 
MAF2 = 0.5, and LD between SNP 1 and 2 = 0.9 (measured by D’).  Figures 4.3A and 
4.3B show the results from simulations of datasets with 500 and 2000 samples, 
respectively.  Although the distribution of LRTem appears to follow a noncentral χ2 
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distribution with df = 3 (the distribution predicted for both runs) in Figure 4.3A, the fit is 
improved in Figure 4.3B.  Furthermore, only the KS test results for the run with a sample 
size of 2000 support the idea that LRTem follows the predicted distribution (KS34.0,3 test 
p-value = 0.145 and KS8.5,3 test p-value = 0).  Figures 4.3C and 4.3D display the 
distribution of LRTem for datasets of 500 and 2000 samples, respectively, simulated for 
haplotypes comprised of two SNPs where MAF1 = 0.01, MAF2 = 0.01, and LD between 
SNP 1 and 2 = 0 (measured by D’).  The predicted distribution for both experimental runs 
is a noncentral χ2 distribution with df = 2; however, the distribution of LRTem in Figures 
4.3C and 4.3D seems to bear a greater resemblance to a noncentral χ2 distribution with 
df = 3.  For the run with 2000 samples, the results of the KS test support the idea that 
LRTem follows a noncentral χ2 distribution with df = 3 (KS13.1,3 test p-value = 0.286 and 
KS13.1,2 test p-value = 0). 
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Figure 4.3  Histograms displaying the distribution of LRTem under H1 for the two SNP 
scenario 
 
Legend for Figure 4.3: The histograms display the distribution of LRTem computed from 
simulated datasets comprised of 500 samples (A and C) and 2000 samples (B and D) along with 
the density lines for several noncentral χ2 distributions.  The distribution of LRTem was created by 
simulating haplotypes comprised of two SNPs under H1.  For (A) and (B), MAF1 = 0.5, 
MAF2 = 0.5, and LD between SNP 1 and 2 = 0.9 (measured by D’) while for (C) and (D), 
MAF1 = 0.01, MAF2 = 0.01, and LD between SNP 1 and 2 = 0 (measured by D’).  10,000 
replicate datasets containing equal numbers of cases and controls were simulated.  The graphs 




Examination of the distributional properties of LRTem under the null and 
alternative hypotheses.  For our simulations under the null and alternative hypotheses 
that rely on haplotype frequencies from the Horan dataset, LRTem did not follow the 
distribution predicted by equation (4.4).  Figure 4.4 displays histograms for LRTem 
computed from simulations utilizing haplotype frequencies from the Horan dataset as the 
generating haplotype frequencies.  Figures 4.4A and 4.4C show the distribution of LRTem 
for a haplotype comprised of 5 SNP markers (for data simulated under H0 and H1, 
respectively) while Figures 4.4B and 4.4D show the distribution of LRTem for a 
haplotype comprised of 10 SNP markers (for data simulated under H0 and H1, 
respectively).  The simulations providing the data for Figures 4.4 created 1000 replicate 
datasets, each containing 2000 samples (equal numbers of cases and controls).  For the 
haplotype simulations under H0 or H1 involving 5 SNP markers, the distribution predicted 
by equation (4.4) is a central or noncentral (ncp = 64.6), respectively, χ2 distribution with 
4 degrees of freedom.  Figures 4.4A and 4.4C demonstrate that the distribution of LRTem 
more closely approximates a central χ2 distribution with 5 degrees of freedom.  The KS0,5 
test (under H0) p-value of 0.099 and the KS64.6,5 test (under H1) p-value of 0.163 confirm 
this similarity (while the KS0,4 and KS64.6,4 had p-values of 0). When the number of SNPs 
included in the haplotype is increased to ten for simulations under H0 or H1, the 
distribution predicted by equation (4.4) is a central or noncentral (ncp = 85.3), 
respectively, χ2 distribution with 19 degrees of freedom.  Figures 4.4B (under H0) and 
4.4D (under H1) show that the distribution of LRTem more closely approximates a central 
χ2 distribution with 20 degrees of freedom and a noncentral χ2 distribution with 18 
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degrees of freedom, respectively.  The results from the KS tests indicate that there is the 
most evidence to support the idea that, under H0, LRTem is distributed as a central χ2 
distribution with 21 degrees of freedom (KS0,21 p-value = 0.054) and, under H1, LRTem is 
distributed as a noncentral χ2 distribution with 18 degrees of freedom (KS85.3,18 
p-value = 0.342).  However, under H1, a noncentral χ2 distribution with 19 degrees of 
freedom is also consistent with the data (KS85.3,19 p-value = 0.243). 
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Figure 4.4  Histograms displaying the distribution of LRTem for simulations based on 
haplotype frequencies from the Horan dataset 
 
Legend for Figure 4.4: The histograms display the distribution of LRTem computed from 
simulations based on haplotype frequencies from the Horan dataset along with the density lines 
for several central χ2 distributions.  The distribution of LRTem was created by simulating 
haplotypes comprised of (A) 5 SNP markers and (B) 10 SNP markers under H0 and haplotypes 
comprised of (C) 5 SNP markers and (D) 10 SNP markers under H1.  1000 replicate datasets 
containing 2000 samples (equal numbers of cases and controls) were simulated.  The graphs were 
scaled to the observed data, and density lines off the scale were truncated. 
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The rule described by equation (4.4) had some success in determining the 
distribution of LRTem for the simulations under H0 and H1 based on haplotype 
frequencies from the HAPMAP TAP2 dataset.  Figures 4.5A and 4.5C show the 
distribution under H0 and H1, respectively, for a haplotype comprised of 5 SNP markers 
while Figures 4.5B and 4.5D show the distribution under H0 and H1, respectively, for a 
haplotype comprised of 10 SNP markers.  The simulations providing the data for 
Figures 4.5A and 4.5C created 1000 replicate datasets with 2000 samples (equal numbers 
of cases and controls) while the simulations providing the data for Figures 4.5B and 4.5D 
created 1000 replicate datasets with 500 samples (equal numbers of cases and controls).  
For the haplotype simulations involving 5 SNP markers, the distribution predicted by 
equation (4.4) under H0 or H1 is a central or noncentral (ncp = 76.3), respectively, χ2 
distribution with 9 degrees of freedom.  In Figure 4.5A, the distribution of LRTem under 
H0 falls between central χ2 distributions with 9 and 10 degrees of freedom.  Although the 
p-values for the KS tests are small, they favor a central χ2 distribution with 9 degrees of 
freedom (KS0,9 p-value = 0.006).  The distribution of LRTem under H1 presented in 
Figure 4.5C does not resemble the predicted noncentral χ2 distribution but instead 
appears to be derived from a noncentral χ2 distribution with many fewer degrees of 
freedom.  When we increased the number of SNPs to ten, both under H0 and H1 equation 
(4.4) predicted that LRTem would follow a central χ2 distribution with 16 degrees of 
freedom.  According to Figures 4.5B and 4.5D, the distribution of LRTem falls between 
central χ2 distributions with 16 and 17 degrees of freedom.  The KS test results under H0 
indicate that LRTem most likely follows a central χ2 distribution with 17 degrees of 
freedom (KS0,17 p-value = 0.750).  (Interestingly, before rounding, equation (4.4) 
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predicted df = 16.4.)  Figure 4.5D shows that, under H1, LRTem appears to follow a 
noncentral χ2 distribution with df = 16 and ncp = 18.0 (KS18.0,16 p-value = 0.628).  Thus, 
under H0 and H1, equation (4.4) demonstrated an ability to predict the approximate 
correct degrees of freedom for the multi-marker haplotypes simulations although it 
lacked consistency for exacting precision. 
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Figure 4.5 Histograms displaying the distribution of LRTem for simulations based on 
haplotype frequencies from the HAPMAP TAP2 dataset 
 
Legend for Figure 4.5: The histograms display the distribution of LRTem computed from 
simulations based on haplotype frequencies from the HAPMAP TAP2 dataset along with the 
density lines for several central χ2 distributions.  The distribution of LRTem was created by 
simulating haplotypes comprised of (A) 5 SNP markers and (B) 10 SNP markers under H0 and 
haplotypes comprised of (C) 5 SNP markers and (D) 10 SNP markers under H1.  1000 replicate 
datasets containing (A and C) 2000 samples and (B and D) 500 samples (equal numbers of cases 
and controls) were simulated.  The graphs were scaled to the observed data, and density lines off 
the scale were truncated. 
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Table 4.3  Summary table for the results from all experimental runs presented 
Scenario Hypothesis MAF1 MAF2 LD between SNP 1 and SNP 2 (D') Category Code
0.5 0.5 0.0 1 
0.5 0.01 0.0 2 H0 
0.01 0.01 0.0 3 
0.5 0.5 0.9 2 
Two SNP 
H1 0.01 0.01 0.0 3 
Scenario Hypothesis Dataset Number of SNPs in Haplotype Category Code
5 3 H0 
10 3 
5 3 H1 
Horan 
10 3 








Legend for Table 4.3:  This table summarizes the results for all experimental runs presented in 
section 4.3.  The category codes are defined as: 1) experimental runs where the rule described in 
equation (4.4) successfully predicts the correct distribution; 2) experimental runs where the rule 
described in equation (4.4) successfully predicts the correct distribution for larger sample sizes 
only; and 3) experimental runs where the rule described in equation (4.4) fails to predict the 
correct distribution regardless of sample size. 
 
4.4 Discussion 
Even for the multi-SNP scenario where the range for the possible degrees of 
freedom of the χ2 distribution is much wider (from 1 to 2b, where b is the number of 
SNPs comprising the haplotype), the rule described in equation (4.4) was fairly consistent 
in predicting the χ2 distribution closest to the distribution of LRTem within a few degrees 
of freedom.  However, while the rule sometimes predicted the correct distribution of the 
test statistic, it was not consistently accurate.  Because of this inconsistency, we advocate 
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applying permutation and simulation methods to empirically generate the distribution of 
the test statistic under the null and alternative hypotheses, respectively, rather than 
applying the rule in equation (4.4).  Future research is required to investigate alternative 
threshold settings and refine the prediction capability of this rule.  
Knowing the precise distribution of a test statistic under the null and alternative 
hypotheses can be extremely practical.  This knowledge allows researchers the freedom 
to employ the distribution to determine the statistical significance (distribution under H0) 
and power (distribution under H1) of the test rather than relying on more computationally 
intensive methods such as permutation and simulation to generate the null and alternative 
distributions empirically.  Of course, reliance on a classically defined distribution (e.g. 
normal distribution, central χ2 distribution, F distribution, etc.) that does not accurately 
describe the distribution of a statistic under the null and alternative hypotheses can lead to 
erroneous estimates of the type I error and power.  In such cases, empirical techniques 
such as permutation and simulation are necessary even at the expense of computational 
resources.  Often, this compromise is inconsequential when analyzing a real dataset.  In 
fact, with modern computer processors and efficiently written code thousands of 
permutations can generally be performed in a reasonable timeframe.  The limitation of 
this approach is often only apparent when many tests, all requiring a separate permutation 
procedure, are performed.  Obviously, this situation arises for genome scans but can also 
be present for a haplotype-based association study that employs a sliding window 
approach across the SNPs in a single candidate gene. 
Estimating low haplotype frequency estimates while computing LRTem is 
somewhat analogous to constructing a sparse contingency table.  However, methods that 
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utilize observations from a contingency table exhibit two qualities not available to 
likelihood-based methods that rely on haplotype frequency estimates – 1) a clear 
guideline defining when the central χ2 distribution can be applied to determine the 
statistical significance and 2) the ability to combine categories containing rare 
observations.  Unless Cochran’s rule is violated (five or more observations in each cell of 
the contingency table), the central χ2 distribution can be applied to determine the 
statistical significance for Pearson χ2 or likelihood ratio statistics that utilize a 
contingency table (Cochran 1952).  We have been unable to establish a parallel guideline 
for likelihood-based statistics that rely directly on haplotype frequency estimates.  In 
addition, rare observations can be pooled (Sham and Curtis 1995; Schaid et al. 2002; 
Zhao et al. 2003) to produce a contingency table that is no longer sparse and contains a 
reduced number of categories.  While frequency estimates for rare haplotypes can be 
pooled, for LRTem the EM algorithm computes the likelihood during the haplotype 
frequency estimation step.  Thus, pooling does not affect the computation of the statistic.  
The likelihood could be computed in a subsequent step using the multinomial distribution 
after haplotype frequencies were estimated and low haplotype frequency estimates were 
pooled.  However, this approach is contrary to a key feature of LRTem in that it treats 
expected counts from the estimates as observations rather than working directly with 
estimates.  By working directly with haplotype frequency estimates in the expression for 
the likelihood, LRTem avoids assumptions regarding the “observed” counts required for a 
contingency table. 
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CHAPTER 5:  DISCUSSION 
 
5.1 Synopsis 
Although haplotypes can provide a powerful tool for gene mapping (Martin et al. 
2000; Akey et al. 2001; Fallin et al. 2001; Morris and Kaplan 2002; Zaykin et al. 2002; 
Botstein and Risch 2003; Clark 2004), several factors add to the complexity of haplotype-
based association studies relative to other forms of genetic association.  First, in common 
practice, original observations are multilocus genotypes, which lack phase information.  
Consequently, estimation or inference procedures are required to apply a haplotype-based 
test.  Second, haplotypes are a combination of alleles at multiple loci generally resulting 
in a large number of haplotypic variants.  In the context of association studies, a large 
number of variants corresponds to many degrees of freedom and often a less powerful 
test.  Third, as the number of marker loci comprising a haplotype grows, the number of 
possible haplotypic variants increases exponentially; however, many of these variants are 
not present in the population even though they may have positive frequency estimates.  
The complexity caused by these factors surfaces in several issues uniquely present in 
haplotype-base studies of association (as compared with other genetic association tests).  
For this thesis, we have developed work aimed at addressing several of these issues 
inherent in tests of haplotype-based association.  Specifically, these issues include 1) the 
multiple testing problem introduced by employing hierarchical clustering to group similar 
haplotypes; 2) haplotype misclassification resulting from statistically inferring haplotype 
pairs from multilocus genotypes; and 3) uncertainty predicting the precise distribution of 
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the haplotype-based association test statistic when haplotype frequency estimates are very 
small or zero.   
In the first part of this thesis, we examined the practice of applying a hierarchical 
clustering to haplotypes and then performing statistical tests at each step in the resulting 
hierarchy in the framework of multiple testing.  To determine the empirical significance 
level or global p-value of the experiment, we proposed a method that takes into account 
the clustering process as well as the correlation structure of the tests performed.  We 
applied our approach to datasets from haplotype association and microarray expression 
studies where hierarchical clustering has been used.  In all of the cases we examined, we 
found that relying on one set of classes in the course of clustering leads to significance 
levels that are too small when compared with the significance level associated with an 
overall statistic that incorporates the process of clustering.  In other words, relying on one 
step of clustering may furnish a formally significant result while the overall experiment is 
not significant. 
In the second portion of this work, our simulations showed that the 
misclassification present in calling phased haplotypes from multilocus genotypes using 
statistical methods is complete.  That is, each misclassified haplotype pair is consistently 
misclassified as the same incorrect haplotype pair throughout the entire dataset.  In 
addition, our simulations under the null hypothesis of no association demonstrate that 
applying the central χ2 distribution to evaluate the significance of test statistics produces 
conservative and anticonservative p-values while applying permutation methods 
consistently produces p-values that maintain the nominal false positive rate.  
Consequently, permutation methods should be exclusively used to determine statistical 
130 
significance for the tests we perform.  As expected, the LRTae provides the greatest 
advantage in terms of power over the LRTstd in situations where more haplotype 
misclassification errors are present.  These situations arise when the haplotype under 
investigation is comprised of many SNP markers with low pair-wise intermarker LD. 
For fixed costs, the power gain of the LRTae over the LRTstd varied depending on 
the relative costs of genotyping, molecular haplotyping, and phenotyping.  In general, the 
LRTae showed the greatest benefit over the LRTstd when the cost of phenotyping was very 
high relative to the cost of genotyping.  This situation is likely to occur in a candidate 
gene replication study as opposed to a genome-wide association study.  For intermediate 
phenotyping to genotyping cost ratios (e.g. 25/ =gp CC ), the LRTae may still provide a 
power advantage if the cost ratio of molecular haplotyping to genotyping is low 
(C  for 10/ <gmh C 5.0≥α ).  Currently, inexpensive long-range PCR methods for 
molecular haplotyping are under development.  As technology improves leading to less 
expensive molecular haplotyping methods, the LRTae will become applicable to a wider 
set of circumstances. 
The final part of this thesis proposes a rule for predicting the distribution of a 
likelihood-based statistic that relies on haplotype frequency estimates.  The rule 
consistently predicted the χ2 distribution closest to the distribution of the statistic within a 
few degrees of freedom even for haplotypes containing many SNP markers.  However, 
the rule did not consistently predict the distribution of the test statistic with pinpoint 
accuracy.  Because of this inconsistent performance, we do not advocate applying the 
predicted distribution to determine statistical significance or power.  Instead, permutation 
and simulation techniques should be employed to generate the distribution of the statistic 
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under the null hypothesis for determination of type I error and under the alternative 
hypotheses for determination of power, respectively. 
 
5.2 Future Directions 
This thesis introduces unique approaches for researchers utilizing haplotypes in 
case-control study designs to localize disease genes.  The approaches proposed overcome 
pitfalls in analyzing datasets; however, they also have several limitations.  One such 
limitation that is relevant for all three strategies described above is the means for 
computing type I error.  In each case, permutation proves to be the most reliable method 
because of the possibility of sparse datasets.  However, there are computational costs for 
this reliability.  With modern processor speeds, analyses which utilize a large number of 
permutations can be performed in a practical amount of time.  However, in the case of 
our computation of the global p-values for datasets where hierarchical clustering has been 
applied, the procedure is computationally more intensive.  After permuting the data to 
compute null statistics, the procedure requires a myriad of comparisons between these 
null statistics (at the same step in the hierarchy) to compute null p-values.  As a result, 
this procedure can be time-consuming, especially if the hierarchy created by clustering 
contains many steps.  Similarly, the computational time required for permutation can be a 
factor when many association tests are performed at different locations in the genome, as 
is the case for a genome-wide scan.  In addition, this situation arises for haplotype-based 
association studies within a single candidate gene that use a sliding window across the 
SNP markers in the gene.  Permutation can be a valuable tool; however, the researcher 
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needs to be aware of the context of the application to plan for the time required for the 
procedure. 
Aside from the computational issues, some limitations are inherent in the 
statistical methods themselves.  For example, the LRTae procedure relies on haplotype 
pairs to detect association.  As stated above, the number of haplotypes present can be 




w , where w is the number of inferred haplotypes) resulting in many degrees of 
freedom for this test.  Tests with larger degrees of freedom are generally equated with a 
loss in power.  Thus, methods which examine single haplotypes (Schaid et al. 2002; 
Zaykin et al. 2002; Stram et al. 2003) rather than haplotype pairs may be more powerful 
than LRTae.  Future research will need to compare the power for these approaches with 
that of the LRTae.  Another option is to develop a version of the Cochran-Armitage 
Linear Test of Trend (Cochran 1954; Armitage 1955; Czika and Weir 2004) which 
incorporates a double-sampling procedure to correct for haplotype miscalls.  Unlike the 
LRTae which makes no assumptions regarding a disease model, the Cochran-Armitage 
Linear Test of Trend relies on specific weights for each risk category and has only one 
degree of freedom.  As a result, this test has the potential to be very powerful relative to 
other haplotype-based association tests, especially with the added capability of allowing 
for haplotype misclassification.  However, specifying the incorrect disease model can 
negatively impact the power of the test (Freidlin et al. 2002).  Future research will need to 
develop this test and assess its robustness to incorrect model selection. 
Another potential limitation of LRTae is that the method assumes non-differential 
misclassification between cases and controls in estimating haplotype misclassification 
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rates.  However, this assumption is not necessarily valid.  A future research direction is to 
extend LRTae to estimate haplotype misclassification rates separately from cases and 
controls.  Presumably, this feature will increase the effectiveness of the test. 
In our power studies of LRTae and LRTstd, we used the entire dataset to infer 
haplotype pairs for each individual.  We chose this approach because 1) it is conservative 
in terms of the power analysis (since differences between haplotype pair frequencies in 
cases and controls should not be as great); 2) the EM algorithm shows improved accuracy 
for haplotype frequency estimates when larger sample sizes are used (Fallin and Schork 
2000); and 3) the EM algorithm assumes Hardy-Weinberg equilibrium, and one is more 
likely to violate this assumption when analyzing cases and controls separately.  However, 
in practice researchers are more likely to examine cases and controls separately while 
inferring haplotype pairs.  Presumably, the power will increase for both LRTae and LRTstd 
for an analysis conducted in this fashion; however, the relative power gain is not clear.  
Additional studies are required to assess the power of LRTae relative to LRTstd for data 
analyzed with this alternative inference scheme. 
Finally, our rule for determining the distribution of LRTem did not consistently 
provide a precisely accurate prediction.  In some cases, a larger sample size improved the 
rule’s accuracy.  There are a number of possible explanations for this improvement.  
First, an increased sample size reduces the sparseness of the dataset.  Second, an 
increased sample size improves the accuracy of the haplotype frequency estimates.  
Third, an increased sample size decreases the frequency threshold for distinguishing 
haplotypes present in the sample from those that are not present.  Future research is 
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required to refine the prediction rule by investigating alternative algorithms for 
determining the thresholds for the estimated haplotype frequencies. 
Technological advancements, in the form of SNP chips and online databases, 
have provided the capability to cost-effectively assay and manage hundreds of thousands 
of SNP markers throughout the genome (Smith 2005).  With this explosion of genetic 
data, haplotype-based association studies have tremendous potential to localize disease 
genes.  Specifically, genotypes are available genome-wide with an average density less 
than a kilobase.  Prior to SNP chip technology which allows for this great density of 
genetic information, genome-scans were performed at substantially lower densities, such 
that the markers were in linkage equilibrium with one another and haplotype-based 
association analyses were less meaningful.  Now the desire for molecular haplotypes 
presents a new technological frontier.  Currently, the perception among molecular 
biologists appears to be that molecular haplotyping is too expensive to warrant 
widespread use.  However, the cost of molecular haplotypes over small regions of the 
genome can be roughly equivalent to that for performing fluorescent polymerase chain 
reactions (Proudnikov et al. 2004; Proudnikov et al. 2006).  In addition, industry has 
shown a serious interest in developing resources to reduce the cost of longer-range 
molecular haplotypes (Smith 2005).  As molecular haplotyping becomes more affordable 
and hence more commonly used, the approaches explained in this thesis will continue to 




Expression Brief Description        
gC  cost of genotyping 
mhC  cost of molecular haplotyping 
pC  cost of phenotyping 
gp CC  cost ratio of phenotyping to genotyping 
df  degrees of freedom for the (central or noncentral) χ2 distribution  
D’ standardized LD parameter, ( )1'0 ≤≤ D  
Dmax  maximum possible LD 
DAF disease allele frequency 
if  penetrance associated with possessing i copies of the disease allele 
g number of variables in a (fractional) factorial design 
hj or   population haplotype frequency of the jjh∗
th haplotype (consisting of 
exclusively of marker loci) 
jh0  haplotype frequency in cases of the j
th haplotype  
jh1  haplotype frequency in controls of the j
th haplotype 
h+,j  frequency of disease-marker haplotype containing the wild-type 
allele (+) at the disease locus and the marker haplotype j 
hd,j frequency of disease-marker haplotype containing the disease 
allele (d) at the disease locus and the marker haplotype j 
1i




th multilocus genotype 
jĥ∗  frequency estimates using all samples for the j
th haplotype 
jĥ0  frequency estimates using cases alone for the j
th haplotype 
jĥ1  frequency estimates using controls alone for the j
th haplotype 
Hi set of haplotype pairs compatible with the ith multilocus genotype 
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21 ,, jji
I  conditional (on case status i) haplotype pair frequency for 
haplotype pair j1, j2 
3, ji
I  conditional (on case status i) haplotype frequency for haplotype j3 
J number of total possible haplotypes 
k number of haplotype pairs 
KSvj the Kolmogorov-Smirnov (KS) test for a χ2 distribution with 
noncentrality parameter (ncp) of v and degrees of freedom (df) of j 
)ln( ,1 aeL  log-likelihood of data, where haplotype pair frequencies ' are 
allowed to differ among different phenotype classes 
t
jip '
)ln( ,0 aeL  log-likelihood of data , where haplotype pair frequencies ' are 
constrained to be equal among different phenotype classes 
t
jip '
)ln( ,1 stdL  log-likelihood of data when not correcting for misclassification, 
where haplotype pair frequencies are allowed to differ among 
different phenotype classes 
jip '
)ln( ,0 stdL  log-likelihood of data when not correcting for misclassification, 
where haplotype pair frequencies are constrained to be equal 
among different phenotype classes 
jip '
L likelihood of the data 
0H
L  likelihood of the data under the null hypothesis 
1H
L  likelihood of the data under the alternative hypothesis 
∗L   likelihood computed from the multilocus genotypes from cases and 
controls together 
0L  likelihood computed from the multilocus genotypes from cases 
alone 
1L  likelihood computed from the multilocus genotypes from controls 
alone 
137 
LD(j) amount of deviation from the equilibrium value for a disease-
marker haplotype comprised of the jth marker haplotype and either 
the wild type or disease allele. 
LRTstd standard likelihood ratio statistic (computed from contingency table) 
LRTae likelihood ratio statistic allowing for errors (computed from 
contingency table) 
 ' jjm  number of individuals that have been classified by the fallible 
method as haplotype pair j and by the infallible method as 
haplotype pair , where 'j kjj ≤≤ ',1  (where k is the number of 
haplotype pairs) 
 '+jm  number of individuals that have been classified by the infallible 
method as haplotype pair , where 'j kj ≤≤ '1  (where k is the 
number of haplotype pairs) 
m number of permutations 
)(min ii p  minimum of local p-values 
MAFj minor allele frequency at the jth SNP locus 
n number of steps in hierarchy 
)1(
'' jjin  number of individuals with (true) phenotype category , true 




' jin  number of individuals with (true) phenotype category  and 
observed haplotype pair category  
'i
j
ncp noncentrality parameter for the noncentral χ2 distribution  
N sample size for the LRTstd 
NDS sample size for the LRTae 
NDS* sample size for the LRTae determined fromα  
),...,,( 21 npppp =
r  vector of local p-values  
pmin global p-value 
pd  allele frequency of disease-causing allele at the disease locus 
p+  allele frequency of the wild-type allele at the disease locus 
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jip '   observed population frequency of haplotype pair for individuals 




jip ' '  true population frequency of haplotype pair for individuals with 




jp '*  true population frequency of haplotype pair under the null 







j ppp '*'1'0 ==
t
iq '  true sampling frequency of phenotype  'i
gmh CCr =  cost ratio of molecular haplotyping to genotyping 
1R  genotype relative risk for the heterozygote 
2R  genotype relative risk for the homozygote 
s number of genetic variants 
t  total number of individuals (used to determine a threshold from 
haplotype frequencies) 
0t  number of cases (used to determine a threshold from haplotype 
frequencies) 
1t  number of controls (used to determine threshold from haplotype 
frequencies) 
u  mean vector 
V variance-covariance matrix 
w number of haplotypes (consisting of exclusively of marker loci) 
jx∗  indicator function for the j
th haplotype (associated with frequency 
estimates using all samples) 
jx0  indicator function for the j
th haplotype (associated with frequency 
estimates using only cases) 
jx1  indicator function for the j
th haplotype (associated with frequency 
estimates using only controls) 
),...,,( 21 nXXXX =
r
 vector of statistical values (generic) 
Xnull matrix of null statistics 
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jX  event that an individual has observed haplotype pair kjj ≤≤1,  
(where k is the number of haplotype pairs) 
t
jX '  event that an individual has true haplotype pair  (where 
k is the number of haplotype pairs) 
kjj ≤≤ '1,'
t
jiX ''  event that an individual has phenotype )1,0'(,' =ii and true 
haplotype pair kjj ≤≤ '1,'  (where k is the number of haplotype 
pairs) 
t
iY '  event that an individual has phenotype )1,0'(,' =ii  
 Yi multivariate normal random variable transformed from null local 
p-value at ith step in hierarchy 
α double-sample proportion 
α  mean double-sample proportion 
δ posterior probability threshold for the threshold double-sample 
selection method 
∗η  number of haplotypes estimated using all samples 
0η  number of haplotypes estimated using controls alone 
1η  number of haplotypes estimated using cases alone 
 ' jjθ  misclassification probability that the true haplotype pair  will be 
misclassified as haplotype pair  
'j
j
φ  disease prevalence 
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ELECTRONIC RESOURCE INFORMATION 
 
 
The adenocarcinoma dataset published by Garber et al. (Garber et al. 2001) can be found 
at http://genome-www.stanford.edu/lung_cancer/adeno/index.shtml. 
 
The B-cell lymphoma dataset published by Alizadeh et al. (Alizadeh et al. 2000) can be 
found at http://llmpp.nih.gov/lymphoma/. 
 
The documentation for StatXact 5 software can be found at http://www.cytel.com/. 
 




The documentation for PAWE can be found at 
http://linkage.rockefeller.edu/derek/pawe1.html.  
 
Data for the estimation of haplotype frequencies from SNP markers within the TAP2 
gene were downloaded from http://www.hapmap.org/downloads/index.html.en 
(HapMap public release #16c.1). 
 
LRTae software is available at ftp://linkage.rockefeller.edu/software/lrtae. 
 
EHP software is available at http://linkage.rockefeller.edu/yyang/resources.html. 
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